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Vaccine effects or other health-related treatments are important to the field of public health.
Causal effects can go beyond simple association to determine whether a treatment is effective
in reducing a disease, for example. In infectious diseases, one person’s treatment may affect
another individual’s outcome. This is known as interference. Causal inference with interference
can be a powerful tool in the benefits of vaccines or other treatments. This work considers
methods for drawing inference about causal effects in cluster-randomized trials and observational
studies in the presence of interference.
Cluster-randomized trials are often conducted to assess vaccine effects. Defining estimands
of interest before conducting a trial is integral to the alignment between a study’s objectives and
the data to be collected and analyzed. The first paper considers estimands and estimators for
overall, indirect, and total vaccine effects in trials where clusters of individuals are randomized
to vaccine or control. The scenario is considered where individuals self-select whether to
participate in the trial and the outcome of interest is measured on all individuals in each cluster.
Unlike the overall, indirect, and total effects, the direct effect of vaccination is shown in general
not to be estimable without further assumptions, such as no unmeasured confounding. An
illustrative example motivated by a cluster-randomized typhoid vaccine trial is provided.
In the setting of observational studies with partial interference, inverse probability weighted
estimators have previously been developed. Unfortunately, these estimators are not well suited
for studies with large clusters. Therefore, in the second paper, the parametric g-formula is
extended to allow for partial interference. G-formula estimators are proposed of overall effects,
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spillover effects when treated, and spillover effects when untreated. The proposed estimators
can accommodate large clusters and do not suffer from the g-null paradox that may occur in the
absence of interference. The large sample properties of the proposed estimators are derived, and
simulation studies are presented demonstrating the finite-sample performance of the proposed
estimators. The Demographic and Health Survey from the Democratic Republic of the Congo is
then analyzed using the proposed g-formula estimators to assess the overall and spillover effects
of bed net use on malaria.
In the third paper, g-estimation is extended to the case of partial interference where different
treatment policies are of interest. This partial interference setting means that individuals within a
cluster may interfere with one another, but they cannot interfere with individuals in other clusters.
In this setting, prior work has focused on inverse probability weighting and the parametric
g-formula. However, inverse probability weighting does not handle large cluster sizes well.
The parametric g-formula relies upon a correctly specified outcome model. G-estimation is
able to handle larger clusters and is not subject to the g-null paradox, providing an alternative
method for this setting. Additionally, g-estimation is doubly robust and is thus more robust to
model misspecification than the parametric g-formula. G-estimators of overall effects, spillover
effects when treated, and spillover effects when untreated are considered. The large sample
properties of the proposed estimators are derived using estimating equation theory. A set of
simulation studies are presented to demonstrate the finite-sample performance of the proposed
estimators. The 2013-14 Demographic and Health Survey in the Democratic Republic of the
Congo is analyzed to determine the causal effect of bed net use on malaria.
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CHAPTER 1: LITERATURE REVIEW
1.1 Introduction to Causal Inference
Causal inference was developed in order to go beyond associations found in general
statistical inference and make causal claims. Neyman [1935] started the potential outcomes
framework, which was later developed more by Rubin [1974]. In this framework, potential,
or counterfactual, outcomes are all possible outcomes for a particular study. Some of these
potential outcomes are not observable.
To elucidate this idea, let there be i = 1, . . . , n individuals in a study with a binary
treatment A. Let Ai = 1 indicate that individual i received treatment and let Ai = 0 indicate that
individual i did not receive treatment. For simplicity, let there be a binary outcome Y , where
Yi = 1 indicates that individual i experienced the outcome of interest and Yi = 0 indicates
that individual i did not experience the outcome of interest. Define the potential outcome for
individual i as Y ai ; Y
a=1
i indicates the outcome for individual i that would have been observed if,
possibly counter to fact, individual i received treatment. Similarly, Y a=0i indicates the outcome
for individual i that would have been observed if, possibly counter to fact, individual i did
not receive treatment. The causal effect of treatment versus no treatment can be written as
Y a=1i − Y a=0i . Under causal consistency, discussed by Cole and Frangakis [2009], the observed
outcome can be written in terms of the potential outcomes: Y = Y a=1A + Y a=0(1 − A). If
individual i receives treatment, then Yi = Y a=1i and Y
a=0
i is unobserved since an individual
cannot both receive and not receive treatment. This idea is called the fundamental problem of
causal inference [Holland, 1986]: since both potential outcomes cannot be observed on the same
unit, it is impossible to observe the effect of the treatment on that unit. The treatment effect
must therefore be estimated from observed data.
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Rubin [1980] detailed the stable unit treatment value assumption (SUTVA), which is fre-
quently used in causal inference framework. This assumption states that there is no interference
between units, meaning that the treatment status of one individual does not affect the the out-
come of another individual [Cox, 1958]. Under this framework, there is only one version of
treatment and one version of control.
Randomized controlled trials (RCTs) are the gold standard in research since randomization
enables the comparison of the treated and untreated groups. In RCTs, when the randomization
is done properly, association is causation [Hernán and Robins, 2006]. However, it is not
always possible to conduct a randomized trial and observational data must be used. Since
treated and untreated are generally not comparable in the observed population, association is
no longer causation [Hernán and Robins, 2006]. Two common methods for causal inference in
observational studies are the parametric G-formula and inverse probability weighting (IPW).
A less commonly used method is g-estimation, perhaps due to a lack of off-the-shelf software
[Vansteelandt and Joffe, 2014]. The parametric G-formula consists of the g-computation
algorithm introduced by Robins [1986] and outcome regression. This method is based on
standardization [Hernán and Robins, 2006]. IPW essentially creates a pseudo population
where each individual in the study appears twice: once as treated, once as untreated. This is
accomplished by weighting the population with the inverse of the conditional probability of
receiving the treatment status that each person received [Hernán and Robins, 2006]. Horvitz
and Thompson [1952] were the first to create these IPW type estimators. A downfall of the IPW
method is that when these weights are small, the estimator becomes very large and difficult to
calculate.
A common assumption in observational studies is that the potential outcomes are indepen-
dent of treatment given a set of measured covariates. Let L represent the measured covariates.
This assumption can be written as Y a ⊥ A|L and is often called conditional exchangeability
[Hernán and Robins, 2006]. Since the potential outcomes are only independent of treatment
given L, this assumption means that all possible confounders (covariates that affect both the
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outcome and treatment) must be in L. In other words, there are no unmeasured confounders.
Another assumption that is commonly used is positivity. In words, positivity says that there
must be at least one individual for each treatment status for every combination of observed L
[Westreich and Cole, 2010]. In math, this can be represented as P (A = a|L) > 0 for a ∈ (0, 1)
when f(L) 6= 0.
Generally, causal effects can be defined in terms of a contrast function g(x, y) where
g(x, x) = 0. One such causal contrast is the causal risk difference, which can be defined as
E[Y a=1] − E[Y a=0]. In order to be a causal effect, the causal contrast must be defined over
the same set of units [Rubin, 1974, Frangakis and Rubin, 2002]. A unit could be defined as
an individual or a cluster for example. Additionally, in order to be a causal effect, the causal
contrast must be in terms of the same outcome under different counterfactual scenarios.
1.2 Causal Inference with Interference
When an individual’s treatment status may affect another individual’s outcome, this is
known as “interference” between individuals [Cox, 1958]. In the context of infectious diseases,
one individual’s vaccination status could affect whether or not another individual gets infected.
In the presence of interference, Halloran and Struchiner [1991] define the direct, indirect, total,
and overall effects of treatment. The direct effect of treatment is the effect of treatment that is
not attributable to interference. The indirect effect of treatment is typically thought of as the
effect of treatment on those who did not receive the treatment, but indirect effects can also be
defined in individuals who received treatment. If this effect exists, it is solely due to interference.
The total effect is the effect of receiving treatment, as well as the effect of others receiving
treatment. Finally, the overall effect is the effect of treatment among all individuals for different
counterfactual scenarios. Halloran and Struchiner [1995] define these treatment effects in terms
of potential outcomes.
When individuals within groups can interfere with each other but not with individuals
in other groups, this is known as “partial interference,” as described by Sobel [2006]. This
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assumption may be reasonable if the groups of individuals are sufficiently separated by distance
or time. If individuals are able to interfere with all other individuals, this is known as general
interference. Interference can make the definition of causal estimands difficult. Previously,
without interference, there were two potential outcomes that an individual could experience
for a binary treatment. With interference, a particular individual can experience much more
than two potential outcomes based on the possible treatments that the surrounding individuals
receive.
Hudgens and Halloran [2008] proposed estimands of the direct, indirect, total, and overall
effects of treatment in a two-stage randomized trial. In these trials, clusters are assigned to a
treatment allocation program with the individuals within those clusters subsequently assigned
to treatment or control based on the allocation program of their cluster. Under this study
design, Hudgens and Halloran [2008] obtain unbiased estimates of the estimands, as well as
the variance of the estimators. However, it is not always possible to run a randomized trial.
Tchetgen Tchetgen and VanderWeele [2012] developed IPW estimators in observational data
where interference may be present. Perez-Heydrich et al. [2014] developed asymptotic variance
estimators when the propensity score is modeled using M-estimation theory from Stefanski
and Boos [2002]. Liu et al. [2019] proposed doubly robust estimators for causal inference with
partial interference.
Causal inference with interference is not only studied in the context of infectious diseases.
For example, causal inference has been studied in spatial analyses [Zigler et al., 2012, Graham
et al., 2013], medical imaging [Luo et al., 2012], criminology [Verbitsky-Savitz and Raudenbush,
2012], econometrics [Sobel, 2006, Manski, 2013, Arpino and Mattei, 2016], political science
[Bowers et al., 2013, Keele and Titiunik, 2015], and social media and network analysis [Ugander
et al., 2013, VanderWeele and An, 2013, Toulis and Kao, 2013, Kramer et al., 2014, Eckles
et al., 2016, Athey et al., 2018]. These are just a few examples of papers in different fields that
use causal inference with interference, but this demonstrates that it is a popular area of study
with many interesting problems to solve.
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1.3 Cluster-Randomized Trials
Cluster-randomized trials are often conducted when randomizing at the individual level is
not feasible or practical [Halloran et al., 2010]. In these trials, individuals are placed into groups
depending on particular characteristics, such as a school or residential neighborhood. These
groups are then randomized to treatment or control. Cluster-randomized trials allow for the
estimation of the treatment’s overall impact on a population, which is especially useful when
treatments may have indirect effects [Hayes et al., 2000]. In some cluster-randomized vaccine
trials, such as those described in Moulton et al. [2001], Diallo et al. [2019], Sur et al. [2009b],
the control is also a vaccine. This helps ensure blinding in the study, allowing for clusters to be
comparable.
Recently, the International Council on Harmonization (ICH) has published a draft addendum
to the E9 guidelines that describes the need to carefully define estimands in clinical trials
and provides guidance on possible estimands of interest [for Harmonisation of Technical
Requirements for Pharmaceuticals for Human Use., 2019]. This addendum is currently in the
process of being revised and finalized. Defining the estimands of interest before conducting a
trial helps align the goals of the trial and the data and reduces the chances of using questionable
assumptions when analyzing the data [Mehrotra et al., 2016]. There have been papers published
that provide examples of estimands of interest in clinical trials; e.g., see Leuchs et al. [2015],
Koch and Wiener [2016], Permutt [2016], Phillips et al. [2017].
There have been several papers that describe estimands in cluster-randomized trials. For
example, Wu et al. [2014] provide estimands for matched-pair cluster-randomized trials. As
previously mentioned, Hudgens and Halloran [2008] provide estimands of different treatment
effects in two-stage randomized trials. When individuals can be categorized as always-takers,
compliers, and never-takers in clustered encouragement designs, Frangakis et al. [2002] provide
estimands of interest. Kang and Keele [2018] discuss cluster-randomized trials with noncompli-
ance where individuals are categorized into the three principal strata as Frangakis et al. [2002],
as well as the case where there are only two principal strata when there are no always-takers.
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However, the study considered in Kang and Keele [2018] does not have blinding, so the treat-
ment effects of interest, the total and indirect effects, cannot be identified. Due to the lack of
blinding, some individuals’ principal strata membership is unknown. However, these papers
have not considered the causal estimands in cluster-randomized trials with partial interference
where individuals are able to choose whether or not to participate in the trial. Chapter 2 of this
document concerns itself with such estimands.
While cluster-randomized trials can be useful in certain situations, there are some disadvan-
tages to this trial design. Because individual outcomes within a given cluster may be correlated,
clustering must be taken into account as ignoring the correlation within the clusters can result
in anti-conservative inference [Bennett et al., 2002]. Because intervention coverage and effect
magnitude may vary across populations, cluster-randomized trials may not be generalizable
[Hayes et al., 2000]. The disadvantages of cluster-randomized trials mean that it is vital to
properly define and incorporate clusters into the design and analysis stages of a trial [Hayes
et al., 2000, Campbell et al., 2004]. To aid in this process, the CONSORT guidelines have been
extended to cluster-randomized trials [Campbell et al., 2004]. There can also be imbalances
in covariates between clusters, but there are methods that can address this problem. Moulton
[2004] describes a trial design method for constrained randomization based on covariates that
may be related to the trial outcome. Clusters can also be matched to minimize the chance
imbalance of covariates. However, this does not always result in perfect balance. Wu et al.
[2014] provide a method to correct for covariate imbalances between clustered pairs while still
providing causal estimands that are relevant to public health policies. When cluster-randomized
trials are not optimal for conducting a study, observational studies can be useful. Chapters 3 and
4 propose causal estimands for observational studies with partial interference.
1.4 Parametric G-Formula
As mentioned above, the parametric G-formula is based on standardization and combines
the g-computation algorithm of Robins [1986] with parametric outcome regression [Hernán and
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Robins, 2006]. This method provides an alternative way to estimate causal effects other than
using the IPW method. The IPW estimator can perform poorly when the weights are small (such
as when the positivity assumption is violated), but the parametric G-formula does not suffer from
such issues [Westreich et al., 2012]. The parametric G-formula in the case of no interference
can be written as E[Y a] =
∫
E[Y |A = a,L = l]dFL(l). The estimator corresponding to this
estimand can be written as
Ê[Y a] =
∫
Ê[Y |A = a,L = l]dF̂L(l)







where Ê[Yi|Ai = ai,Li] can be estimated with an outcome regression model. For a binary
outcome Y , a logistic regression could be performed to obtain these estimates. The parametric
G-formula has been used to adjust for time-varying confounders in time to event data [Taubman
et al., 2009, Young et al., 2011, Westreich et al., 2012, Cole et al., 2013, Garcia-Aymerich
et al., 2014, Keil et al., 2014]. When the parametric components are correctly specified, the
parametric G-formula estimator is more efficient than the IPW estimator for this setting [Young
et al., 2011]. Common parameters of interest are the risk ratio [Taubman et al., 2009, Cole et al.,
2013, Garcia-Aymerich et al., 2014] or the hazard ratio [Westreich et al., 2012, Keil et al., 2014].
These parameters typically answer the question of what happens when everyone is treated versus
when everyone is not treated.
Unfortunately, the parametric G-formula can suffer from the “g-null paradox.” Under this
paradox, the necessary parametric models may not be possible to correctly specify under the
null hypothesis. This results in the rejection of the null hypothesis in large samples, even if
the null hypothesis is true [Robins, 1986, Taubman et al., 2009, Cole et al., 2013]. Another
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downfall of the parametric G-formula, as well as any of the other g-methods that use parametric
models, is that model misspecification can result in bias [Taubman et al., 2009].
1.5 G-Estimation
G-estimation was proposed for structural nested models in Robins [1989, 1992]. G-
estimation allows for time-varying confounding and assumes no unmeasured confounders
[Sterne and Tilling, 2002]. Typically, logistic regression models are fit for a range of possible
values of ψ, the parameter of interest, where exp(−ψ0) is the ratio of the survival time for a
continuously exposed person to the survival time for someone who was never exposed, with ψ0
denoting the g-estimate [Sterne and Tilling, 2002]. G-estimation can use information about the
exposure distribution a priori [Vansteelandt and Joffe, 2014].
For structural nested mean models, additive rank preservation within the levels of the
covariates is important in g-estimation. Additive rank preservation means that the effect of
treatment is the same on the additive scale on the outcome for all individuals in the population
of interest. A simple structural nested mean model that assumes the average causal effect across
strata of L is the following:
E[Y a − Y a=0|A = a, L] = β1a
The additive rank preservation is incorporated with the use of another model:
Y Ai − Y a=0i = ψ1a
such that ψ1 = β1. This is equivalent to Y a=0i = Y
a
i − ψ1a, or Y a=0i = Y − ψ1A with causal
consistency. If this model is correctly specified and ψ1 known, then Y a=0i could be calculated
for all individuals. However, ψ1 is typically not known and is the target of inference. For each
individual,
H(ψ†) = Y − ψ†A
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is computed for all possible values of ψ†, usually over a grid search. For example, separate
logistic regression models logitP [A = 1|H(ψ†), L] = α0 + α1H(ψ†) + α2L can be fit and
the value of H(ψ†) with α̂1 ≈ 0 is the counterfactual value of Y a=0i . The corresponding
value of ψ† is then the estimate of the true value of ψ1. For this setting, there is a closed




, or in estimating equation formatting, the solution to∑
iHi(ψ
†)(Ai − Ê[Ai|Li]) = 0. 95% confidence intervals can be constructed by obtaining a
subset of the ψ† where p > 0.05 for Wald tests. Alternative tests such as the score or likelihood
ratio test could be used instead. Note that g-estimation assumes that conditional exchangeability
holds.
When there is effect modification so the average causal effect is not the same for everyone,
a two-parameter structural nested mean model can be used:
E[Y a − Y a=0|L] = β1a+ β2aV
where V consists of the components of L that are the effect modifiers. The rank preserving
model is then Y ai − Y a=0i = ψ1a + ψ2aV and we let H(ψ) = Y − ψ1A − ψ2AV . A logistic
model logitP [A = 1|H(ψ†), L] = α0 + α1H(ψ†) + α2H(ψ†)V + α3L can be fit and the goal
is to find the combination of values for ψ†1, ψ
†
2 where H(ψ
†) ⊥ A|L, or where α̂1 = α̂2 = 0.
Generally, there is not a closed form solution to this and numerical search algorithms, such as
Nelder-Mead Simplex), need to be used.
Greenland et al. [2008] showed that using g-estimation on randomization status generalizes
the intent-to-treat (ITT) analysis when there may be noncompliance in a randomized trial.
Ten Have et al. [2007] extended g-estimation to the case of a linear rank preserving model
approach with mediation. They found that the method performed well when the assumptions
were met, but when the structural interaction assumptions were not met, this method performed
poorly. Robins et al. [1992] used g-estimation to estimates parameters of a structural nested
failure time model. Witteman et al. [1998] extended g-estimation for time-dependent covariates
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to allow for censoring by competing risks. G-estimation can be used to compare counterfactual
failure times when always exposed versus never exposed.
While there is not much in the way of off-the-shelf software for g-estimation, this method
can be more flexible and perform better than other methods [Vansteelandt and Joffe, 2014].
Continuous exposures or binary exposures that are correlated with covariates are handled better
with g-estimation than with IPW. Additionally, g-estimation performs better than IPW when
the positivity assumption may be violated [Vansteelandt and Joffe, 2014]. Compared to the




While typhoid fever is not common in the United States, it affects many other countries,
particularly developing countries. Crump and Mintz [2010] reported approximately 22 million
cases of typhoid fever in the year 2000. Since typhoid fever can be transmitted via contaminated
water and food, non-vaccine methods of preventing typhoid include improving sanitation and
increasing the presence of safe food and water. As of 2010, there were two available typhoid
vaccines in the United States [Crump and Mintz, 2010].
The Vi polysaccharide vaccine was used in the cluster-randomized trial described by Sur
et al. [2009b]. This was a phase 4 effectiveness trial that took place in Kolkata, India between
2004 to 2006. Individuals were grouped into a total of 80 geographical clusters based on a
census of the population in two wards (administrative units). The clusters were randomized
so that 40 clusters were assigned to the Vi vaccine and 40 were assigned to the control, which
was an inactivated hepatitis A vaccine. Individuals within those clusters were able to choose
whether or not to receive the vaccine to which their cluster was assigned. Sur et al. [2009b]
found significant overall, total, and indirect effects of the Vi vaccine. However, this study did
not use causal methods and therefore cannot make causal conclusions. We intend to introduce
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causal estimand notation to cluster-randomized trials in the context of the Sur et al. [2009b]
trial. Assuming partial interference, we can make causal statements about the overall, total, and
indirect effects of the Vi vaccine.
1.6.2 Malaria in the Democratic Republic of the Congo
According to the world malaria report for 2018 from the World Health Organization (WHO),
there were approximately 219 million cases of malaria worldwide in 2017, with the majority
of cases in the WHO African Region [Organization, 2018]. The Democratic Republic of the
Congo (DRC) was the country with the second largest percentage of malaria cases and was
among three countries with the highest estimated increase in malaria cases. Worldwide, there
were approximately 435,000 deaths from malaria in 2017 with 61% of these deaths in children
younger than 5 years old [Organization, 2018]. The United States alone contributed $3.1 billion
to global control and elimination of malaria. The global burden of malaria is high, so finding
methods to reduce malaria cases is vital.
There were 624 million insecticide-treated mosquito nets (ITNs) delivered worldwide
between 2015 and 2017 according to the WHO [Organization, 2018]. In Africa in 2017,
approximately half of the population used ITNs, but ITN coverage has not increased since 2016.
The goal of the research using the 2013-14 DRC Demographic and Health Survey (DHS) is to
investigate the cases of malaria in those who use bed nets, those who do not use bed nets, and
the entire population as bed net coverage changes.
The 2013-14 Demographic and Health Survey was the second DHS survey in the DRC and
took place from November 2013 to February 2014. This was a nationally representative survey
intended to gather information about fertility, maternal and child health, sexually transmitted
infections, mosquito net usage, malaria, and other health information [Min, 2014]. There were
536 clusters across 26 new provinces (formerly 11 provinces) in the survey. Before combining
clusters, the average number of individuals per cluster is approximately 179 with a standard
deviation of approximately 30. Children between the ages of 6 to 59 months were tested for
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malaria. Blood smear tests and rapid diagnostic tests were used to test for malaria. Before
combining clusters, there were approximately 16 children on average with a standard deviation
of approximately 5 who tested positive for malaria for both types of tests.
1.7 Summary and Proposed Research
Accounting for the possible presence of interference can allow for the calculation of different
treatment effects. This is particularly important for public health policies as there will likely be
a mixture of individuals who will and will not choose to receive treatment, such as a vaccine.
The proposed methods in this dissertation focus on effects beyond the traditional causal effects
defined by comparing the average outcome when all individuals receive treatment versus when
all individuals do not receive treatment. Estimators are proposed for both cluster-randomized
trials and observational data.
In Chapter 2, estimands for the overall, indirect, and total effects of vaccination are defined
for cluster-randomized trials. As there is currently a movement in the literature for clinical
trials to carefully define estimands of interest, the estimands in this chapter can be helpful for
investigators when designing and analyzing a cluster-randomized trial. The motivating example
for this chapter is a cluster-randomized vaccine trial for a Vi polysaccharide (typhoid) vaccine
[Sur et al., 2009b]. In this trial, individuals within clusters chose whether or not to participate.
The overall, indirect, and total effects of vaccination can be defined within different subgroups
of individuals. The proposed methods are applied to simulated data that match exactly the
cluster level summary statistics from the motivating example.
In Chapter 3, the G-formula is extended to the case of partial interference when the scientific
question of interest is the efficacy of different treatment policies. This may be more relevant to
public health policies as there will likely be individuals in the population who do and do not
receive treatment. The estimands of interest are shown to be identifiable from observational data.
The proposed estimators are shown to be consistent and asymptotically normal using estimation
equation theory. The finite-sample performance of the proposed estimators is demonstrated with
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simulations. Finally, the proposed estimators is applied to the 2013-14 DRC Demographic and
Health Survey to investigate the causal effect of bed net use on malaria.
In Chapter 4, g-estimation is extended to the case of partial interference. The estimands of
interest are shown to be identifiable from observed data. The proposed estimators are shown
to be consistent and asymptotically normal using estimation equation theory. The proposed
estimator is evaluated in simulations and illustrated using the DRC bed net data set.
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CHAPTER 2: ESTIMANDS AND INFERENCE IN CLUSTER-RANDOMIZED VAC-
CINE TRIALS
2.1 Introduction
Vaccines are integral to combating a variety of infectious diseases. Quantifying a vaccine’s
effects is vital to determining its benefits, which can then guide public health policies aimed at
reducing the burden of disease. Cluster-randomized trials are often conducted to quantify the
effects of a treatment or intervention such as a vaccine. In cluster-randomized trials, individuals
are grouped together based on certain characteristics (e.g., neighborhood of residence), and the
entire cluster is randomized to treatment or control. The process of randomization ensures that
the treatment and control groups are exchangeable. Cluster-randomization is useful when it is
impractical or infeasible to randomize at the individual level [Halloran et al., 2010]. Comparisons
between randomized clusters can be used to assess the overall impact of an intervention on the
population, which is particularly important in settings where an intervention may have indirect
(or spillover) effects [Hayes et al., 2000]. For example, in the infectious disease setting, whether
one individual is vaccinated could affect the outcome of another individual. Moulton et al.
[2001] describe a cluster-randomized trial in the White Mountain Apache Reservation and the
Navajo Nation wherein approximately 9000 infants within 38 clusters were randomized by
cluster to the vaccine of interest (Streptococcus pneumoniae conjugate vaccine) or control (a
meningococcal C conjugate vaccine). Diallo et al. [2019] present a cluster-randomized trial of
an inactivated influenza vaccine in Senegal in which approximately 7800 enrolled, age-eligible
children within 20 clusters were randomized by cluster to the influenza vaccine or control (an
inactivated polio vaccine). Sur et al. [2009b] describe a cluster-randomized trial of a typhoid
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vaccine in India, with approximately 38000 individuals within 80 clusters randomized by cluster
to the typhoid vaccine or control (hepatitis A vaccine).
Because the cluster-randomized trial is a common study design for evaluating vaccine
effects, it is important to carefully define the estimands, i.e., parameters of interest, in these
trials. Careful definition of the effects of interest prior to the study can aid in study planning
and can ensure that the study’s goals are achieved [Leuchs et al., 2015]. Recently, there has
been increased interest in defining estimands in clinical trials. The International Council on
Harmonization (ICH) has published an addendum to the E9 guidelines detailing the use of
estimands in clinical trials [for Harmonisation of Technical Requirements for Pharmaceuti-
cals for Human Use., 2019]. This addendum aims to describe the necessity of defining the target
estimand before the design and analysis of trials to avoid misalignment of the trial goals and
the data, as well as to ensure that estimation of the estimand is possible without relying upon
dubious assumptions [Mehrotra et al., 2016].
Leuchs et al. [2015], Koch and Wiener [2016], Permutt [2016], and Phillips et al. [2017]
discuss examples of estimands of interest in regulatory clinical trials. Target estimands specif-
ically for cluster-randomized trials have been previously considered for certain designs. Wu
et al. [2014] consider estimands for matched-pair cluster-randomized trials. Hudgens and
Halloran [2008] consider estimands of the direct, indirect, total, and overall effects of treatment
assuming a two-stage randomization scheme. In this design, clusters are randomly assigned to
a treatment allocation program, and individuals within the clusters are randomly assigned to
treatment based on the cluster-level assignment. In some cluster-randomized trials, individuals
may not comply with their randomization assignment or may choose not to participate in the
study [Moulton et al., 2001, Sur et al., 2009b,a, PATH, .]. Frangakis et al. [2002] consider
clustered encouragement designs, which allow noncompliance, where individuals belong to one
of three principal strata: always-takers, compliers, and never-takers. Kang and Keele [2018]
also consider cluster-randomized trials with noncompliance. Like Frangakis et al. [2002], they
consider the setting where there are the three principal strata mentioned above, and also the
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special case where there are no always-takers. Even for this special case, they show the total and
indirect (spillover) effects are not identified because principal strata membership is unknown for
some individuals.
In this paper, we consider cluster-randomized vaccine trials where individuals choose
whether or not to participate in the trial. As illustrated by the examples described above, it is
common in cluster-randomized vaccine trials for the control to be another vaccine which is
not expected to affect the outcome of interest. For simplicity, below the control vaccine will
sometimes be referred to just as a control. Here we consider the particular case where a control
vaccine is employed and individuals are blinded, i.e., unaware whether their cluster is randomly
assigned to the vaccine of interest or to the control vaccine. In this setting, it is reasonable to
assume individual participation behavior is unaffected by randomization, such that there are only
two principal strata: always participators and never participators. Thus, our setting is similar
to the special case considered by Kang and Keele [2018]. However, because it is assumed an
individual will participate or not in the trial regardless of randomization assignment, principal
strata membership is known for all individuals; this allows for identification and estimation of
overall, total and indirect effects.
Sur et al. [2009b] provides a motivating example of a cluster-randomized vaccine trial
where individuals self-select whether to participate. In this trial, clusters of individuals were
randomized to either a typhoid vaccine or a control vaccine (for hepatitis A). The presence of a
control allowed study blinding, so individuals in the clusters did not know which assignment
their cluster received. While some individuals chose not to participate in the trial, outcome data
was collected on all individuals. This allows inference about different effects of the vaccine, as
described below.
The outline of the remainder of this paper is as follows. In Section 2.2, notation, estimands,
estimators, and effects of interest are described. In Section 2.3, the Sur et al. [2009b] cluster-
randomized typhoid vaccine trial is considered. Finally, Section 2.4 concludes with a discussion.
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2.2 Methods
2.2.1 Notation and Potential Outcomes
Consider a cluster-randomized vaccine trial with n clusters (or groups) of individuals where
each cluster is randomly assigned to vaccine or control. For i = 1, . . . , n, let Ai = 1 if cluster i
is assigned to vaccine and Ai = 0 otherwise. Let Y a=1i denote the potential outcome if cluster i
is assigned vaccine, and let Y a=0i denote the potential outcome if cluster i is assigned control.
For example, Y a=1i could denote the proportion of individuals in cluster i who would develop
typhoid within one year after randomization if, possibly counter to fact, cluster i were assigned
to vaccine. For now, we leave the particular outcome associated with Y ai unspecified. Different
specifications of Y ai will correspond to different vaccine effects, as described below. Let Yi
denote the observed outcome for cluster i, such that Yi = Y a=1i Ai + Y
a=0
i (1− Ai). Below, the
subscript i is sometimes dropped for notational convenience.
In cluster-randomized vaccine trials, one individual’s vaccination status may affect another
individual’s outcome, that is, there may be “interference” between individuals [Cox, 1958]. For
instance, if one individual receives a typhoid vaccine, this could affect whether or not another
individual develops typhoid. Throughout this paper, it is assumed that there is no interference
between individuals in different clusters, i.e., there is “partial interference” [Sobel, 2006]. Under
this assumption, the outcome Yi for cluster i depends only on the treatment assigned to cluster i.
No assumption is made regarding the form of interference within clusters.
2.2.2 Estimands and Estimators
Vaccine effects, i.e., the causal effects of vaccination, can be defined by contrasts in the
expected values of the potential outcomes Y a=1 and Y a=0. Assuming the n clusters in the
trial are randomly sampled from an infinite super-population of clusters, the average treatment
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(vaccine) effect is generally defined by
θ = E[Y a=1]− E[Y a=0] (2.1)
where E[X] denotes the expected value of X in the super-population of clusters. In words,
(2.1) is the difference in the average outcome in the super-population when a cluster receives
a = 1 compared to when a cluster receives a = 0. Alternatively, the n clusters could be
considered the finite population of interest and E[X] defined instead to be n−1
∑n
i=1Xi. The
super-population perspective is adopted in this paper, but similar considerations to those provided
here apply if the finite population approach is utilized instead. Likewise, estimands other than
(2.1) could be considered. For example, for binary Y , the risk ratio E[Y a=1]/E[Y a=0] =
Pr[Y a=1 = 1]/Pr[Y a=0 = 1] might be of greater interest than the risk difference (2.1). For
instance, Y might be an indicator of whether or not at least one individual in a cluster gets
infected [Bjune et al., 1991, Halloran et al., 2002]. More generally, causal effects can by
defined by g(E[Y a=1], E[Y a=0]) for some contrast function g(x, y) where g(x, x) = 0; e.g.,
g(x, y) = x − y corresponds to (2.1). Below, estimands of the form (2.1) are described, but
similar considerations apply for other contrasts.
A few aspects of defining causal effects bear mentioning. First, causal effects are typically
defined by contrasts in expected values of the potential outcomes over the same set of units
[Rubin, 1974, Frangakis and Rubin, 2002]. In many settings, the unit is defined to be an
individual; for example, a unit could be a participant in a randomized controlled trial. Here,
we consider the clusters to be the units since randomization is at the cluster level. Note that
contrasts in average potential outcomes between different sets of units do not have a causal
interpretation. For example, suppose a cluster-randomized vaccine trial is conducted in schools,
where students within the same school constitute the clusters. A comparison of the average
Y a=1 among clusters (schools) in rural areas to the average Y a=0 among clusters in urban areas
is not a causal effect. Also note that causal effects are contrasts in the expected value of the
same outcome under different counterfactual scenarios. Contrasts in different outcomes are not
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causal effects. For example, a comparison of the average incidence of typhoid when clusters
receive vaccine with the average incidence of cholera when clusters receive control would not
be a causal effect. We will revisit this point below when discussing direct effects.











YiI(Ai = 0) (2.2)
where na =
∑n
i=1 I(Ai = a) for a = 0, 1. This estimator is consistent and unbiased under
commonly used randomization schemes, such as a completely randomized experiment where the
number of clusters assigned vaccine (treatment) is fixed [Miratrix et al., 2013, Imbens and Rubin,
2015, Athey et al., 2018]. The standard error of θ̂ can be estimated and 95% Wald confidence
intervals can be constructed in the usual manner for the difference in means. Equivalently, (2.2)
can be obtained by computing the least squares estimate of the slope parameter of simple linear
regression of Y on A. A generally more precise estimator can be obtained by regressing Y
on A and Z where Z is some vector of baseline covariates. For simplicity, only estimators of
the form (2.2) are considered below; see Tsiatis et al. [2008] for further discussion on using
baseline covariates to improve efficiency. Note also that (2.2) utilizes only cluster level data
and thus avoids the complexities associated with inference based on statistics constructed using
individual level data, which require accounting for possible within-cluster correlation (e.g.,
using mixed effects models or generalized estimating equations).
2.2.3 Overall, Indirect, and Total Effects
In this section, the general approach above is used to define estimands and estimators of the
overall, indirect, and total effects. The outcome of interest will depend on the context of the
vaccine trial, such as the infection or pathogen of interest, the target population, and so forth.
Here, the outcome of interest is generically referred to as disease.
The overall effect compares the average disease outcome among all individuals when a
cluster is assigned vaccine versus when a cluster is assigned control. This quantity may be
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the most relevant to public health policy because all individuals within clusters are used in the
comparison. As it is likely that populations of interest will include a mixture of individuals who
would and who would not choose to be vaccinated, the overall effect may be valuable for public
health officials and policy makers in assessing the overall impact of a vaccine at the population
level.
The overall effect estimand and estimator can be defined in terms of individual level
outcomes as follows. Let mi denote the number of individuals in cluster i. For individual j
in cluster i, let Yij = 1 if individual j develops disease, and let Yij = 0 otherwise. Let Y a=1ij
indicate the outcome that would have been observed for individual j if cluster i is randomized to
vaccine, and define Y a=0ij analogously for control, such that Yij = Y
a=1
ij Ai + Y
a=0
ij (1−Ai). For
the overall effect, the estimand (2.1) can be expressed in terms of individual potential outcomes










ij /mi for cluster i. The overall
effect estimator can likewise be expressed in terms of the observed individual-level outcomes
by letting Yi =
∑mi
j=1 Yij/mi.
The indirect effect quantifies the effect of vaccination on individuals who chose not to
participate in the trial and, therefore, have no chance of receiving the vaccine. This effect is
defined as a contrast in the average outcomes among non-participants when their cluster does
or does not receive vaccine [Halloran and Struchiner, 1991]. Because the indirect effect is
defined only among individuals who never receive the vaccine, this effect (if present) is solely
due to interference. Thus, indirect effects are a type of spillover or peer effect [Sobel, 2006].
Quantifying indirect effects may be of interest from a public health policy perspective because
vaccinating some, but not all, individuals within a cluster can still provide benefits to those who
are unable or choose not to be vaccinated.
Like the overall effect, the indirect effect estimand and estimator can be defined in terms of
individual level outcomes. To do so, first define the potential outcome Sa=1ij where S
a=1
ij = 1
if individual j in cluster i would choose to participate in the trial if, possibly counter to fact,









ij (1−Ai). Assume Sa=1ij = Sa=0ij , i.e., an individual’s decision to participate
is not affected by whether their cluster is assigned vaccine or control. This assumption may
be reasonable in cluster-randomized trials where individuals are blinded, such as the typhoid
vaccine trial described in Section 2.3, because in such settings, randomization is not expected
to have an effect on an individual’s decision to participate in the trial. As mentioned in the
Introduction, Frangakis and Rubin [2002] and Kang and Keele [2018] utilize the principal
stratification framework when considering non-compliance in cluster-randomized trials. Under
the assumption Sa=1ij = S
a=0
ij , all individuals belong to one of two principal strata: always
participators, i.e., individuals where Sa=1ij = S
a=0
ij = 1; and never participators, i.e., individuals
where Sa=1ij = S
a=0
ij = 0. Fortunately, unlike the setting considered by Kang and Keele, here
the principal strata membership of each individual can be inferred directly from the observed
data because Sij = Sa=1ij = S
a=0
ij .
The indirect effect is the effect of vaccine in the non-participator principal stratum. The






























. This estimand compares the average disease outcome among non-participators when
a cluster is assigned vaccine versus when a cluster is assigned control. Similarly, the in-







j=1 I(Sij = 0)
}
.
The total effect measures the effect of treatment in the always participator principal stratum.
Because always participators receive the vaccine if and only if their cluster is assigned vaccine,
the total effect encompasses both the individual effect of receiving the vaccine as well as the
effect of other individuals in the cluster being vaccinated. The total effect estimand and estimator
have the same form as the indirect effect estimand and estimator described above, but with
Sa=1ij = 0 replaced by S
a=1
ij = 1, S
a=0
ij = 0 replaced by S
a=0
ij = 1, and Sij = 0 replaced by
Sij = 1. The total effect quantifies the difference in the average disease outcome among always
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participators when a cluster is assigned vaccine versus when a cluster is assigned control. The
total effect is often the effect of primary interest in this type of trial. An illustration of the
overall, indirect, and total effects is given in Figure 2.1.
There are a few special cases of note. In the scenario where all individuals in the population
are willing to participate in trials (i.e., there are no non-participators), the indirect effect is
not well-defined, and the total and overall effects are equivalent. In some trials, only a subset
of individuals may be eligible to be randomized for vaccination. For example, in Sur et al.
[2009b], individuals were eligible if they were at least two years of age, were not pregnant or
lactating, and did not have an elevated temperature when the vaccine was given. Indirect effects,
analogous to that defined above for non-participators, can be defined and estimated in these
individuals if their outcome of interest is measured.
Figure 2.1: Cluster counterfactual comparisons. The left circle represents a cluster if, possibly
counter to fact, assigned to vaccine (A = 1). The right circle represents a cluster if, possibly
counter to fact, assigned to control (A = 0). Within each circle, S indicates which individuals
chose to participate in the study (S = 1 indicates participation, S = 0 otherwise). The overall,
indirect, and total effects are contrasts in average potential outcomes over different sets of
individuals within the clusters.
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2.2.4 Direct Effect
The overall, indirect, and total effects each describe an effect of treatment (vaccination)
which is at least partially due to interference, if present. The effect of treatment that is not
attributable to interference may also be of interest. Such an effect is sometimes referred to as a
direct effect. This section describes why it is not possible in general to estimate the direct effect
of vaccination in a cluster-randomized trial with self-selection of participation without additional
assumptions, such as no unmeasured confounding. Informally, the direct effect compares the
average outcome when an individual is vaccinated to the average outcome when an individual
is not vaccinated, holding fixed the proportion of other individuals vaccinatedHalloran and
Struchiner [1991]. Several formal definitions of the direct effect estimand have been proposed;
e.g., see Hudgens and Halloran [2008], VanderWeele and Tchetgen Tchetgen [2011], Liu et al.
[2016], Eck et al. [2018] and Sävje et al. [2018].
To develop intuition behind the lack of identifiability of the direct effect, consider the
following naive approach. Suppose the proportion of vaccinated individuals with disease is
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I(Ai = 1). (2.3)
By the law of large numbers, (2.3) converges to
E[Y a=1]− E[Ỹ a=1] (2.4)



























. Unfortunately, the estimand (2.4) is not a causal effect,




noted above, for an estimand to have a causal interpretation, the same outcome must be compared
under different counterfactual scenarios.
It is conventional, although not incontrovertible [Pearl, 2018], to define causal effects
only for a treatment or exposure that is manipulable, i.e., there can be “no causation without
manipulation” [Holland, 1986]. If this convention is followed, then in cluster-randomized trials
with non-participation, the direct effect of vaccination would only be considered well defined
in always participators. Otherwise, to define the relevant potential outcomes would require
considering a counterfactual scenario where non-participators receive vaccine. However, for
the study design under consideration, always participators receive vaccine if and only if other
always participators in their cluster also receive vaccine. Thus it is not possible to observe both
(i) a vaccinated always participator and (ii) an unvaccinated always participator, while holding
fixed the proportion of other individuals who are vaccinated in the cluster; hence the direct
effect is not identifiable without additional assumptions.
On the other hand, if the “no causation without manipulation” convention is not adopted,
there are other complications that may arise with estimating the direct effect. In particular, in
cluster-randomized trials with non-participation, vaccine coverage within a cluster is dictated by
the collective level of individual participation in the study, which is not under the investigator’s
control. Factors associated with participation may also be associated with the outcome of
interest, creating the potential for confounding. Thus causal inference methods for observational
studies, such as those assuming no unmeasured confounding, would in general be necessary
to draw inference about direct effects. To be concrete, consider the counterfactual scenario (or
policy) where individuals independently receive vaccine with probability α. Let Aij denote the
vaccination status of individual j in cluster i, and let Ai = (Ai1, Ai2, . . . , Aini). The random
vector Ai takes on values ai in the set A(ni) = {0, 1}ni . Let Yij(ai) denote the potential
outcome for individual j (in cluster i) corresponding to ai. The potential outcomes Yij(ai) may
also be expressed as Yij(ai,−j, aij) where ai,−j denotes the vector of treatment indicators for all
individuals except individual j and aij is the treatment indicator for individual j. Define the
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Yij(ai,−j = b, aij = 1)Pα(Ai,−j = b)
where Pα denotes the probability under policy α. Define Yij(0;α) analogously such that
Yij(0;α) is the average outcome for individual j when not vaccinated under policy α. Then
define the direct effect under policy α to be
E[Ȳi(1;α)]− E[Ȳi(0;α)] (2.5)
In the cluster-randomized trial setting considered in this paper, individuals self-select whether
to participate such that it would be dubious to assume treatment received is independent of an
individual’s potential outcomes. However, in some settings, it might be reasonable to assume
there exists some vector of baseline covariates, say Li, such that the set of potential outcomes for
individuals within cluster i are conditionally independent of the treatment selected given these
covariates, i.e., Yij(ai) ⊥ Ai | Li. This is a cluster level version of the usual no unmeasured
confounders assumption. Under this assumption, inverse probability weighted estimators have
been proposed which are consistent for (2.5) [Tchetgen Tchetgen and VanderWeele, 2012,
Perez-Heydrich et al., 2014].
2.3 Typhoid Vaccine Trial
A cluster-randomized study was conducted to investigate the effectiveness of a Vi polysac-
charide typhoid vaccine in Kolkata, India over two years of follow-up from 2004 to 2006 [Sur
et al., 2009b]. The control in this trial was an inactivated hepatitis A vaccine. Geographic
mapping and a census that characterized and counted all people and households in the study
area were used to define 80 clusters. For purposes of randomization, clusters were stratified by
ward (an administrative unit of Kolkata) and by the number of residents in certain age groups.
Overall, 40 clusters were assigned to Vi vaccine and the other 40 to control. Because data
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from the typhoid trial are not publicly available, a simulated data set was constructed (see Data
Availability Statement). The data were simulated to match exactly the cluster level summary
statistics from the actual trial shown in Table 2.1.
Table 2.1: Summary statistics of a cluster-randomized study in Kolkata from 2004 to 2006 of
a Vi typhoid vaccine versus a hepatitis A control vaccine [Sur et al., 2009b]. SD: standard
deviation
Typhoid Vaccine Control
Number of clusters 40 40
Mean ± SD of people per cluster 777 ± 136 792 ± 142
Mean ± SD of participants per cluster 472 ± 103 470 ± 104
Number of participants 18869 18804
Number of non-participants 12206 12877
Number of events in participants 34 96
Number of events in non-participants 16 31
Sur et al. [2009b] measure vaccine effects in terms of hazard ratios. However, causal
interpretations for hazard ratios are difficult because hazard ratios can depend on time and have
an inherent selection bias [Hernán, 2010]. In particular, time-specific hazard ratios compare
different subsets of subjects and, as noted above, estimands have a causal interpretation only
when comparing potential outcomes between the same set (or subset) of units. Due to these
issues, instead of using the hazard ratio to determine the vaccine effects as in Sur et al. [2009b],
the risk difference of typhoid over two years is calculated here to quantify vaccine effects.
The overall, indirect, and total effects were estimated using (2.2) with the Yi definitions
provided in section 2.2.3. The effect estimates, estimated standard errors (SEs), and 95% Wald
confidence intervals (CIs) are shown in Table 2.2. For example, the overall effect estimate was
obtained by taking the difference in the average number of cases of typhoid per 1000 individuals
between Vi clusters and control clusters. In particular, Vi clusters had 1.61 cases of typhoid per
1000 people, while control clusters had 4.10 cases of typhoid per 1000 people. Thus, the overall






}1/2 where σ̂a denotes the estimated standard error for clusters
26
assigned a = 0 (control), 1 (Vi). Finally, a 95% Wald CI was estimated in the usual manner
with a result of (-3.41, -1.58). The overall effect estimate has a straightforward interpretation
which may be of interest to public health officials such as epidemiologists. In particular, the
number of cases of typhoid per 1000 persons over a two year period is estimated to decrease by
2.5 on average when a cluster receives the Vi vaccine compared to receiving control.
Both participants and non-participants appear to benefit from the Vi vaccine. In particular,
over the study period, on average, there were 1.85 cases of typhoid per 1000 participants in Vi
clusters, and 5.15 cases of typhoid per 1000 participants in control clusters. Thus, the total effect
estimate is -3.30 (95% CI -4.61, -1.99), indicating that assigning a cluster to Vi vaccine causes
3.3 fewer cases of typhoid per 1000 participants compared to assigning a cluster to hepatitis A
vaccine. Likewise, Vi clusters had 1.29 cases of typhoid per 1000 non-participants on average,
while control clusters had 2.58 cases of typhoid per 1000 non-participants on average over the
study period. Taking the difference between these values gives an indirect effect estimate of
1.29 (95% CI 0.19, 2.38). The indirect effect estimate suggests that assigning a cluster to the
typhoid vaccine results in 1.29 fewer cases per 1000 non-participants; as non-participants never
receive the vaccine, this indicates an indirect (or herd immunity) effect of the typhoid vaccine.
Table 2.2: Estimates of overall, indirect, and total effects, standard errors (SE), and 95% Wald
confidence intervals (CI). Effect estimates are differences in typhoid cases per 1000 people per
two years.
Effect Estimate (SE) 95% CI
Overall -2.49 (0.47) (-3.41, -1.58)
Indirect -1.29 (0.56) (-2.38, -0.19)
Total -3.30 (0.67) (-4.61, -1.99)
On the other hand, the naive direct effect estimator (2.3) equals 0.56 (95% CI -0.44, 1.55).
Although not statistically significant, this point estimate implies that the average number of
cases of typhoid per 1000 people is higher in vaccinated individuals compared to non-vaccinated
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individuals in clusters randomized to the Vi vaccine. However, as described above, this estimate
cannot be interpreted as an effect of the vaccine as discussed in Section 2.2.4. For example,
perhaps individuals at higher risk of typhoid chose to participate in the trial, or those who
participated tended to have different health care seeking behavior. Moreover, the average
number of cases of typhoid per 1000 people was also higher in participants compared to non-
participants (2.57, 95% CI 1.19, 3.96) in the control clusters, providing direct evidence of
confounding. Sur et al. [2009b] reported similar results, with incidence of typhoid higher in
participants compared to non-participants, both within Vi vaccine clusters and within control
clusters.
2.4 Discussion
Randomized controlled trials are the gold standard in vaccine trials since randomization
ensures that the vaccine and control groups are comparable. Carefully defining estimands
in clinical trials is vital to ensure accurate interpretation of the resulting treatment effect
estimates. Because cluster-randomized trials can be large and expensive to conduct, it is
important to formally characterize estimands for use in these trials. This paper considers causal
estimands in cluster-randomized trials where interference may be present within clusters. An
illustrative example is provided motivated by a recent cluster-randomized typhoid vaccine trial
demonstrating inference and interpretation of the overall, total, and indirect effect estimands.
These types of analyses can be used to inform public health policies regarding vaccination.
In cluster-randomized trials with self-selection, estimators of the direct effect must account
for possible confounding. As described at the end of Section 2.2, a standard method to adjust
for confounding is to condition on covariates and assume that conditional on these covariates,
participants and non-participants are exchangeable. A possible indirect way to adjust for
confounding could involve comparing outcomes between participants and non-participants in
the control clusters as an estimate of the confounding bias, if present, similar to negative control
approaches described in Lipsitch et al. [2010] and Tchetgen Tchetgen [2013]. Alternatively,
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two-stage randomized designs could be considered to eliminate possible confounding when
drawing inference about the direct effect. In two-stage randomized experiments, clusters are
first randomly assigned to a treatment allocation program, then individuals within those clusters
are assigned to treatment or control based on their cluster’s treatment allocation program
[Hudgens and Halloran, 2008]. Randomization eliminates possible confounding at the cluster
and individual level, such that direct, indirect, total, and overall effects can be estimated
[Hudgens and Halloran, 2008, Baird et al., 2018, Basse and Feller, 2018]. However, it may not
always be feasible to conduct two-stage randomized trials. In addition, the effects estimated
by a two-stage randomized experiment are not equivalent to the effects estimated in cluster-
randomized trials with participation self-selection and may have less public health relevance
[Papadogeorgou et al., 2019, Barkley et al., 2020].
Estimated effects may have greater real-world relevance depending on the estimands
of interest and characteristics of individuals in the trials, such as the level of participation.
Westreich [2017] provides several examples of population intervention effects defined by
contrasts in average potential outcomes under different possible interventions on the distribution
of treatment. These population intervention effects may be more germane to real-world policy
than the traditional approach of defining causal effects by comparing average outcomes when
all individuals in the population receive treatment versus when no individuals receive treatment.
The estimands described here for cluster-randomized trials with self-selection are examples of
population intervention effects, to the extent that the participation rate in the trial approximates
vaccination uptake should the vaccine under evaluation become widely available to the public.
For example, in Sur et al. [2009b], about 60% of individuals on average chose to be vaccinated in
both Vi and hepatitis A clusters; thus, the overall, total, and indirect effect estimates approximate
the effects of vaccinating 60% of the population. Such effect estimates could potentially help
inform public health policy decisions regarding vaccination.
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Data Availability Statement
Because data from the typhoid trial are not publicly available, a simulated dataset was
constructed. This dataset is available at https://github.com/KilpatrickKW.
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CHAPTER 3: G-FORMULA FOR OBSERVATIONAL STUDIES WITH PARTIAL IN-
TERFERENCE, WITH APPLICATION TO BED NET USE ON MALARIA
3.1 Introduction
In settings where individuals interact or are connected, one individual’s treatment status may
affect another individual’s outcome, i.e., interference may be present between individuals [Cox,
1958]. Interference is common in infectious disease research. For instance, if one individual
wears a mask, this could affect whether another individual develops COVID-19 (coronavirus
disease 2019). In some settings, it may be reasonable to assume that individuals within a cluster
(or group) may interfere with one another, but not with individuals in other clusters, i.e., there
is “partial interference” [Sobel, 2006]. Clusters might entail households, villages, schools,
or other hierarchical structures. For instance, when assessing the effect of an intervention
or exposure in students, it may be reasonable to assume no interference between students in
different schools. Under this partial interference setting, several methods have been proposed
for drawing inference about causal estimands of treatment effects; e.g., see Tchetgen Tchetgen
and VanderWeele [2012], Papadogeorgou et al. [2019], Barkley et al. [2020].
In the presence of interference, it is of interest to assess the effect of policies which alter
the distribution of treatment in the population. For instance, in the Democratic Republic of the
Congo, public health officials and policy makers may be interested in estimates of malaria risk
for different levels of bed net usage in the population. In observational studies where partial
interference is present, it may be unlikely that treatment selection among individuals in the
same cluster is independent. For example, in household studies of vaccine effects, we might
expect vaccine uptake to be positively correlated between individuals in the same household.
Therefore, estimands that will be most relevant to policy makers need to account for possible
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within-cluster treatment selection dependence. Papadogeorgou et al. [2019] and Barkley et al.
[2020] recently proposed such estimands and developed corresponding inferential methods using
inverse probability weighted (IPW) estimators. These IPW estimators entail inverse weighting
by an estimated group propensity score. Unfortunately, this approach is not well suited for
large groups, because in practice the estimated group propensity score is often near zero when
there are a large number of individuals in a group [Saul and Hudgens, 2017, Chakladar et al.,
2019, Liu et al., 2019]. In the absence of interference, a commonly used alternative to the
IPW estimator is the parametric g-formula, which entails combining outcome regression and
standardization [Robins, 1986, Hernán and Robins, 2006]. This paper proposes an extension of
the parametric g-formula for observational studies where partial interference may be present
which is better suited for large clusters compared to IPW.
The proposed methods were motivated by the 2013-14 Democratic Republic of the Congo
(DRC) Demographic and Health Survey (DHS), a nationally representative survey to gather
information about fertility, maternal and child health, sexually transmitted infections, mosquito
net (hereafter “bed net”) usage, malaria, and other health information [MPSMRM, MSP, and
ICF International, 2014]. In the analysis presented below, population level effects of bed net use
on malaria are assessed using data from the DRC DHS. Figure 3.2 displays province-level bed
net use and the proportion of children who did not use bed nets with malaria. The DHS data were
collected at the household level. For the analysis here, a single linkage agglomerative cluster
method was used to group individuals into clusters based on their household global positioning
system (GPS) coordinates, resulting in a total of 395 clusters with at least one child and measured
spatial information and other covariates. After performing this clustering algorithm, covariates
and bed net use data are available for approximately 87,500 individuals. Malaria outcome
data is available for about 7,500 children between 6 to 59 months (for brevity, henceforth
referred to as ”children”). Among the clusters with at least one child who did not use a bed
net, the prevalence of malaria in children who did not use bed nets is inversely associated with
the proportion of bed net usage in the cluster (Spearman correlation rs = −0.16, p = 0.002),
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suggesting the possibility of interference within clusters. Previously, Levitz et al. [2018] showed
that community-level bed net usage was significantly associated with protection against malaria
in children younger than five years old. The inferential goal in this paper is to assess the
population-level effects of bed use on malaria when varying the proportion of children who use
bed nets.
Figure 3.2: Malaria bed net study in the Democratic Republic of the Congo. Left map: province-
level bed net usage. Right map: prevalence of malaria in children who do not use bed nets.
The outline of the remainder of this paper is as follows. Section 3.2 presents the proposed
extension of the g-formula to allow for partial interference. Section 3.3 presents the simulation
results evaluating the performance of the proposed methods in finite samples. In Section 3.4,
the proposed estimators are employed to assess the effect of bed net use on malaria using data
from the DRC DHS. Section 3.5 concludes with a discussion.
3.2 Methods
3.2.1 Estimands and Effects of Interest
Suppose data is observed on m clusters of individuals, and let Ni denote the number of
individuals in cluster i. Suppose some individuals within each cluster may receive treat-
ment (e.g., bed net) and denote the vector of binary treatment indicators in cluster i as
Ai = (Ai1, Ai2, . . . , AiNi) with Aij representing the treatment indicator for individual j. Let
Si = (
∑Ni
j=1Aij)/Ni denote the proportion of treated individuals in cluster i. Let Yi represent
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the outcome at the cluster level. In general, Yi may be defined differently depending on the
outcome of interest. For example, in the analysis of the DRC data, Yi may be defined as the
proportion of children in a cluster with malaria. Let Li represent a vector of cluster-level
baseline covariates, including Ni. Let Oi = {Li, Si, Yi} be the observed random variables for
cluster i, and assume O1, . . . , Om are independent and identically distributed. For notational
simplicity, the subscript i is omitted when not needed.
Assume partial interference, i.e., there is no interference between clusters, but there may be
interference between individuals within the same cluster. For example, in the DRC analysis,
one individual’s bed net usage may affect whether or not another individual in the same cluster
gets malaria. Let A(Ni) denote the set of all vectors of length Ni with binary entries such that
a = (ai1, ai2, . . . , aiNi) ∈ A(Ni) is a vector of possible treatment statuses for a cluster of size
Ni. For cluster i, let Y ai represent the potential outcome if, possibly counter to fact, the cluster
had been exposed to a ∈ A(Ni), such that Y ai = Yi when Ai = a.
In addition to partial interference, we also assume the cluster level potential outcomes
depend only on the proportion of individuals treated, but not which particular individuals receive
treatment. That is, Y ai = Y
a′
i for any two vectors a, a







this type of assumption is sometimes referred to as “stratified interference” [Hudgens and
Halloran, 2008]. For example, in the DRC analysis, we will assume that the prevalence
of malaria in a cluster only depends on the proportion of bed net users, not which specific
individuals use bed nets. For cluster i, let Y si denote the potential outcome for any a such
that (
∑Ni
j=1 aij)/Ni = s. Assume exchangeability conditional on L at the cluster level, i.e.,
Y s ⊥ S|L.
Population-level effects of interventions such as bed nets can be defined by differences in
expected outcomes when the distribution of treatment is altered. For example, in the absence
of interference, the effect of treatment is often defined by the difference in expected outcomes
when all individuals receive treatment versus when no individuals receive treatment. Here we
consider stochastic policies where individuals receive treatment with some probability between
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0 and 1. Define policy α to be the setting where the expected proportion of individuals in a
cluster who receive treatment is α, i.e., Eα(S) = α, where in general the subscript α denotes the
counterfactual scenario in which the policy α is implemented. For example, the DRC analysis
below considers policies where different proportions of individuals use bed nets.
The expected outcome in a group of individuals under policy α can be expressed as:












s|S = s,L = l)Pα(S = s|L = l)dFαL(l)
where S = {0, 1/n, 2/n, ..., 1} and FαL denotes the marginal distribution of baseline covariates
under policy α. The first line of (3.6) follows from the law of total expectation and the second
line from causal consistency [Cole and Frangakis, 2009]. Effects of interest can be defined by
contrasts in µα for two policies α and α′, e.g.,
δ(α, α′) = µα − µα′ . (3.7)
Here, effects are defined as a difference in average potential outcomes, but ratios or other
contrasts could be used instead. A primary contrast of interest in the DRC analysis is the
difference in the proportion of children infected with malaria under policies α versus α′.
In the DRC analysis, we will consider three different effects of bed nets: the overall effect,
the spillover effect when treated, and the spillover effect when untreated. All three effects have
the form (3.7) but differ in how Yi is defined. The overall effect compares the average outcome
among all individuals in a cluster under policies α versus α′. As it is likely that populations of
interest will include a mixture of individuals who would and who would not choose to receive
treatment, the overall effect may be valuable for public health officials and policy makers in
assessing the overall impact of increasing treatment coverage among a population. For inference
about the overall effect, Yi is a summary measure of outcomes in all individuals in cluster i.
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For the malaria data analysis, Yi is defined to be the proportion of all children in a cluster with
malaria.
Two different spillover effects are also considered. The spillover effect when untreated
contrasts average outcomes when an individual is untreated under policy α versus policy α′. For
this effect, Yi may be defined by some summary measure of outcomes in untreated individuals.
In the DRC analysis of the spillover effect in the untreated, Yi will be defined as the proportion
of children who do not use bed nets with malaria. If there are no untreated individuals in the
cluster, we adopt the convention Yi = 0. Similarly, the spillover effect when treated contrasts
average outcomes when an individual is treated under policy α versus policy α′. For the spillover
effect when treated in the DRC analysis, Yi will be the proportion of children who use bed nets
with malaria, with Yi = 0 in clusters with no treated individuals.
3.2.2 Identifiability
Additional assumptions are made to draw inference about the estimands described above.
Assume FL = FαL, i.e., the distribution of the covariates is the same under the factual and
counterfactual policies. Let πs = g−1(ρ0 + ρ1L), where g is some monotone, user-specified link
function such as logit or probit, and assume





πNss (1− πs)N−Ns. (3.8)
where ρ = (ρ0, ρ1). Likewise, under policy α, let πsα = g−1(γ0α + γ1αL) and assume





πNssα (1− πsα)N−Ns. (3.9)
where γ = (γ0α, γ1α). The parameters ρ in (3.8) are identifiable from the observable data,
whereas the counterfactual parameters γ in (3.9) are not identifiable without additional assump-
tions. As in Barkley et al. [2020], assume ρ1 = γ1α; this assumption implies rank preservation
between clusters in treatment propensity. In other words, if treatment adoption is more likely in
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cluster i than cluster j, then under counterfactual policy α, treatment adoption will also be more
likely in cluster i than cluster j. It follows that πsα = g−1(γ0α + ρ1L) and γ0α is the solution to
∫
l
Eα(S|L = l; γ0α, ρ1)dFL − α = 0 (3.10)
where Eα(S|L = l; γ0α, ρ1) = πsα. Finally, let πy = g−1(β0 + β1L + β2S) and assume
E(Y |S = s,L = l) = E(Y |S = s,L = l; β) = πy (3.11)
where β = (β0, β1, β2). For simplicity, an interaction between S and L is omitted from the
model of E(Y |S = s,L = l) but could be included. Assume that the mean of Y given S,L is
the same under the factual scenario and counterfactual scenario α, i.e., E(Y |S = s,L = l) =
Eα(Y |S = s,L = l).
3.2.3 Inference
Estimators for µα can be constructed as follows. First estimate the parameters ρ = (ρ0, ρ1)
of model (3.8) and β = (β0, β1, β2) of model (3.11) via maximum likelihood; denote these
estimators by ρ̂ = (ρ̂0, ρ̂1) and β̂ = (β̂0, β̂1, β̂2). Next, for a given policy α, let γ̂0α denote the
estimator of γ0α obtained by finding the solution to (3.10) with FL replaced by its empirical
distribution, i.e., m−1
∑m
i=1 Êα(S|Li; γ0α, ρ̂1) − α = 0 where Êα(S|Li; γ0α, ρ̂1) = g−1(γ0α +
ρ̂1Li). Let P̂α(S = s|L) denote (3.9) evaluated using (γ̂0α, ρ̂1), and let Ê(Y |S = s,L = l)






Ê(Y |S = s,L = l)P̂α(S = s|L = l)dF̂L(l)
where F̂L denotes the empirical distribution function of L, and the estimator for the effects
of interest is δ̂(α, α′) = µ̂α − µ̂α′ . The estimators ρ̂, β̂, µ̂α, µ̂α′ , and δ̂(α, α′) are solutions to
unbiased estimating equations (see Appendix A). Therefore, it follows from standard large-
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sample estimating equation theory that the estimators are consistent and asymptotically Normal
[Stefanski and Boos, 2002]. The empirical sandwich estimators, which are consistent estimators
of the asymptotic variances, can be used to construct Wald confidence intervals (CIs).
3.2.4 Population Strata
For the DRC malaria example, the methods described above may be applied directly if
children are considered the population of interest and we ignore data collected from adults.
Such an approach makes inference about counterfactual scenarios regarding the distribution
of bed net usage in children and is agnostic to bed net use by others in the clusters. However,
the DRC DHS includes bed net data for all individuals, which can be utilized to estimate the
effects of bed net usage by all individuals on the risk of malaria in children. To do so, the
approach above can simply be modified by changing the definition of S to be the proportion
of all individuals in the cluster, not just children, who use bed nets. Alternatively, one may
choose to model separately the proportion of children using bed nets (say S1) and the proportion
of other individuals in the cluster using bed nets (say S2). In particular, the population mean







E(Y |S1 = s1, S2 = s2,L = l)Pα(S1 = s1|L = l, S2 = s2)Pα(S2 = s2|L = l)dFL(l)
where policy α is defined such that individuals in strata 1 and 2 are treated with the same
probability: Eα(S1) = Eα(S2) = Eα(S) = α. Inference proceeds analogous to Sections
3.2.2–3.2.3, but with separate parametric models for S1 given L, S2 and for S2 given L; such an
approach is taken in the DRC bed net analysis in Section 3.4.
3.2.5 G-Null Paradox
In the absence of interference, the parametric g-formula may give rise to the so-called g-null
paradox. That is, certain parametric models are guaranteed to be misspecified under the null
hypothesis of no treatment effect. As a result, the null hypothesis of no treatment effect will be
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incorrectly rejected with high probability when the sample size is large [Robins, 1986, Robins
and Wasserman, 1997, Taubman et al., 2009].
For the setting considered in this paper, the null hypothesis is that the proportion treated S
has no effect on the outcome Y , or that µα = µ′α for any two policies α, α
′. If S has no effect
on Y , then β2 = 0 and E(Y |S = s,L) = E(Y |L). Recall E(Y |S = s,L) = Eα(Y |S = s,L).




E(Y |L = l)
∑
s∈S
Pα(S = s|L = l)dαFL(l) =
∫
l
E(Y |L = l)dFL(l) (3.12)
where the second equality follows because
∑
s∈S Pα(S = s|L = l) = 1. The right-hand side of
(3.12) does not depend on α, so the g-null paradox does not occur here.
3.3 Empirical Evaluation
Simulation studies were conducted to evaluate the finite sample properties of the proposed
g-formula estimator. Three separate simulations studies were conducted for the three target
estimands: overall effect, spillover effect when treated, and spillover effect when not treated. For
the overall effect simulation study, 1000 data sets each withm = 125 clusters were stochastically
generated as follows:
(i) The number of individuals per cluster Ni was simulated such that P (Ni = 8) =
0.4, P (Ni = 16) = 0.35, and P (Ni = 20) = 0.25.
(ii) Two cluster level covariates L1i and L2i were generated, where L1i was Normal with
mean 40 and standard deviation 10, and L2i was such that P (L2i = 0) = 5/18, P (L2i =
1) = 3/18, P (L2i = 2) = 4/18, P (L2i = 3) = 5/18, P (L2i = 4) = 1/18.
(iii) For each cluster, the number of treated individuals was drawn from a Binomial distribution
with parameters Ni and πsi = expit(ρ0 + ρ1L1i + ρ2L2i) where ρ = (logit(0.6),−0.01,
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− 0.01). The proportion of individuals treated per cluster, Si, was then calculated by
dividing the number of treated individuals by Ni.
(iv) For each cluster, the outcome Yi was set equal to Xi/Ni where Xi was Binomial with
parametersNi and πyi = expit(β0+β1L1i+β2Si+β3L2i) where β = (logit(0.6),−0.01,
− 0.8,−0.01).
Correctly specified models of Y given S and L, and of S given L were fit by maximum
likelihood. The asymptotic variance of the estimators was estimated using the empirical
sandwich variance estimator, and Wald 95% CIs were calculated with these variance estimates.
The true values of estimands for policies α ∈ {0.4, 0.5, 0.6} were calculated analytically
for the data generating process described above. In particular, the true values of γ0α are the
solutions to (3.10) where πsα = expit(γ0α + ρ1L1 + ρ2L2). The counterfactual probabilities
Pα(S = s|L) for s ∈ S can then be computed via (3.9) based on the true values of γ0α, ρ1, ρ2.
Similarly, E(Y |S = s,L) for s ∈ S may be evaluated using (3.11) and the true value of β.
Finally, the true values of µα can be found using (3.6).
Results for the overall effect simulation study are given in the top third of Table 3.3. The
average bias of the proposed g-formula estimators was negligible, and the CIs contained the
true parameter values for approximately 95% of the simulated datasets. The average of the
estimated sandwich standard errors was approximately equal to the empirical standard errors,
with standard error ratios of approximately 1.
The simulation study described above was repeated for the spillover effect when treated,
with the following modification. In step (iv), the cluster outcome Yi was set equal to Xi/(NiSi)
where Xi was Binomial with parameters NiSi and πyi. If there were no treated individuals in a
cluster, then Yi was set to 0. Results for the g-formula estimator of the spillover effect when
treated are presented in the middle part of Table 3.3. Results are similar to the overall effect,
except the standard error for the g-formula estimator of the spillover effect when treated is larger
because fewer individuals contribute to the outcome.
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Finally, a third simulation study was conducted for the spillover effect when untreated. The
simulation steps above were repeated, but with step (iv) modified such that the cluster outcome
Yi was set equal to Xi/{Ni(1− Si)} where Xi was Binomial with parameters Ni(1− Si) and
πyi, with Yi set to 0 if Si = 1. Results are given in the bottom section of Table 3.3.
Table 3.3: Summary of simulation study results as described in Section 3.3. Truth: true value of
the estimand targeted by the estimator. Bias: average bias of the g-formula estimates over 1000
datasets. Cov%: empirical coverage of Wald 95% CIs. ASE: average of estimated sandwich
standard errors. ESE: empirical standard error. SER: ASE/ESE.
Estimator Truth Bias Cov% ASE ESE SER
All Individuals
µ̂α=0.4 0.418 0.000 94% 0.0147 0.0153 0.96
µ̂α=0.5 0.399 -0.000 94% 0.0119 0.0121 0.98
µ̂α=0.6 0.380 -0.000 94% 0.0145 0.0149 0.97
δ̂(α = 0.6, α′ = 0.4) -0.038 -0.001 94% 0.0172 0.0180 0.95
δ̂(α = 0.6, α′ = 0.5) -0.019 -0.000 94% 0.0084 0.0089 0.95
δ̂(α = 0.5, α′ = 0.4) -0.019 -0.000 94% 0.0087 0.0091 0.96
When Treated
µ̂α=0.4 0.418 -0.002 95% 0.0243 0.0242 1.00
µ̂α=0.5 0.399 -0.001 96% 0.0174 0.0165 1.05
µ̂α=0.6 0.380 0.000 95% 0.0184 0.0178 1.03
δ̂(α = 0.6, α′ = 0.4) -0.038 0.002 93% 0.0255 0.0267 0.96
δ̂(α = 0.6, α′ = 0.5) -0.019 0.001 93% 0.0126 0.0132 0.96
δ̂(α = 0.5, α′ = 0.4) -0.019 0.001 93% 0.0129 0.0135 0.96
When Untreated
µ̂α=0.4 0.418 -0.001 95% 0.0185 0.0188 0.99
µ̂α=0.5 0.399 -0.000 96% 0.0173 0.0167 1.03
µ̂α=0.6 0.380 0.000 96% 0.0235 0.0231 1.02
δ̂(α = 0.6, α′ = 0.4) -0.038 0.001 94% 0.0248 0.0259 0.96
δ̂(α = 0.6, α′ = 0.5) -0.019 0.000 94% 0.0122 0.0127 0.96
δ̂(α = 0.5, α′ = 0.4) -0.019 0.000 94% 0.0126 0.0131 0.96
3.4 Analysis of Bed Net Use on Malaria in the Democratic Republic of the Congo
The methods described above were applied to the DRC DHS survey to draw inference about
the effects of bed nets on malaria in children when varying the proportion of children in this age
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range who use bed nets. As mentioned in Section 3.1, a single linkage agglomerative hierarchical
cluster method [Everitt et al., 2011] was used to group households of individuals into clusters.
The maximum distance between any two households in the same cluster was constrained to
not exceed 10 kilometers. This distance was selected based on the maximum flight distance
of an Anopheles mosquito [Janko et al., 2018]. The GPS coordinates used in the clustering
algorithm were randomly displaced from the actual location to prevent participant identification.
Rural clusters were displaced up to 5 kilometers, while urban clusters were displaced up to 2
kilometers [MPSMRM, MSP, and ICF International, 2014]. Using this clustering algorithm,
there were 395 clusters with at least one child that were not missing spatial information and
other covariates. Figure 3.3 displays the number of children per cluster, as well as the proportion




























































Figure 3.3: Malaria bed net study in the Democratic Republic of the Congo. Left panel: number
of children with a measured malaria outcome per cluster. Right panel: proportion of children
who used bed nets per cluster.
Because malaria was measured only in children, Y , S, and N for each cluster were defined
based only on children with a measured outcome. Exchangeability was assumed conditional on
the cluster-level proportion of women, as well as cluster-level averages of building materials
(described below), urbanicity, altitude, age, temperature in the month of the survey, total
precipitation in a 10 kilometer radius the month before the survey, and proportion of agricultural
land cover within a 10 kilometer radius in 2013. The building material variable was defined
similar to Levitz et al. [2018] where roof and wall materials were summed for each individual
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within a cluster. Natural materials were worth 0 points, rudimentary materials 1 point, and
finished materials 2 points. Hence, for each individual, the building material variable was an
integer between 0 and 4. The link g = logit was used for fitting both the treatment and outcome
models.
Figure 3.4 displays g-formula estimates of the population mean estimands over a range of
policies α ∈ [0.1, 0.9] in all individuals, when treated, and when untreated. The left panel of
Figure 3.4 shows that the overall risk of malaria decreases as α increases, which is not surprising
since bed nets are known to protect against malaria and bed net usage increases with α. The
middle panel of Figure 3.4 demonstrates that the risk of malaria when treated also decreases as
α increases, suggesting the presence of interference. In other words, treated individuals appear
to benefit from others in their cluster also using bed nets. On the other hand, there appears to be
little or no spillover effect when untreated (right panel Figure 3.4).
Estimates of the overall effects, spillover effects when treated, and spillover effects when
untreated for different policies α compared to the current factual policy α′ = 0.55 are displayed
in Figure 3.5. These estimates approximate the expected change in the number of cases of
malaria due to increasing or decreasing bed net use relative to current utilization. For example,
δ̂(α = 0.8, α′ = 0.55) = −0.056 (95% CI −0.076,−0.035) indicates that if 80% of children in
a cluster were to use bed nets, then we would expect 56 fewer cases of malaria per 1000 children
on average. Similarly, for the spillover effect when treated, δ̂(α = 0.8, α′ = 0.55) = −0.077
(95% CI −0.10,−0.054) indicating we would expect 77 fewer cases of malaria per 1000 treated
children on average if 80% of children in a cluster were to use bed nets. On the other hand,
the spillover effect when untreated for α = 0.8 compared to α′ = 0.55 is −0.011 (95% CI
−0.045, 0.023), suggesting no or modest benefit of increasing bed net use to non users.
For sake of comparison, the Barkley et al. [2020] IPW estimator was also applied to the
DRC DHS data to estimate the bed net effects. However, the mixed effects model used to
estimate the group propensity scores did not converge, hence it was not possible to compute
the IPW estimates. Given that the DRC data includes several large clusters, it is not surprising
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Figure 3.4: Estimates of the population mean estimands from the malaria bed net study. The pro-
portion of treated children is denoted by policy α. The shaded regions indicate 95% confidence
intervals.
issues were encountered when attempting to compute the IPW estimator. A possible workaround
would be to exclude the large clusters [Chakladar et al., 2019], but this would inefficiently
discard data and limit generalizability of the results.
The results above are based on clustering of households such that the maximum distance
between any two households in the same cluster was 10 km. Sensitivity analyses were performed
where clusters were instead defined based on maximum distances of 5 km and 2.5 km. There
were 415 clusters in the 5 km analysis and 445 clusters in the 2.5 km analysis that were not
missing spatial information and had at least one child. Population mean estimates were very
similar between the 2.5 km, 5 km and 10 km analyses; see Figure 3.6.
To investigate the effect of changing the proportion of the entire population who use bed
nets, the 10 kilometer clusters were also analyzed using the methods from Section 3.2.4. The
estimated population means for the general population policy compared to the children-only
policy are shown in Figure 3.7. Changes in the general population policy are associated with
greater changes in the mean outcome in all individuals and when treated compared to the
children-only policy. However, the largest difference in estimated population means between
the general population policy and the children-only policy is only 0.05. For the spillover effect
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Figure 3.5: Estimated effects from the malaria bed net study. The proportion of treated children
is denoted by policy α. Effects contrast α with α′ = 0.55, the current factual policy. The shaded
regions indicate point-wise 95% confidence intervals.


























Figure 3.6: Estimates of the population mean estimands from the malaria bed net study. The
proportion of treated children is denoted by policy α. Solid black lines represent 10 km, solid
gray lines represent 5 km, and dashed lines represent 2.5 km clusters.
Everyone Treated Untreated



















Figure 3.7: Estimates of the population mean estimands from the malaria bed net study for the
children-only policy (solid lines) and general population policy (dashed lines).
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3.5 Discussion
In the presence of partial interference, the proposed g-formula estimator is an alternative to
existing IPW estimators, such as those proposed in Tchetgen Tchetgen and VanderWeele [2012].
The g-formula estimator can accommodate large clusters, unlike IPW estimators [Chakladar
et al., 2019, Liu et al., 2019], and does not suffer from the g-null paradox that may occur in the
absence of interference. Like the IPW estimators of Papadogeorgou et al. [2019] and Barkley
et al. [2020], the proposed methods target counterfactual estimands which allow for within
cluster dependence of treatment selection and thus may be more relevant to policy makers.
Consistency of the proposed g-formula estimator requires that the parametric models be correctly
specified; future research could explore relaxing these parametric assumptions, perhaps by using
semiparametric or nonparametric models. While motivated by infectious disease prevention
studies, the g-formula methods developed in this paper are applicable in other settings where
partial interference may be present.
Supporting Information
Code and Data Availability R code to replicate the simulation study is available at
https://github.com/KilpatrickKW. The DRC survey data is available upon re-
quest at http://www.dhsprogram.com and the corresponding spatial data is available at
http://spatialdata.dhsprogram.com.
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CHAPTER 4: G-ESTIMATION WITH PARTIAL INTERFERENCE
4.1 Introduction
In infectious disease research, one individual’s treatment status may have an effect on
another individual’s outcome. This is generally known as “interference” between individuals
[Cox, 1958]. A recent example of interference is with the spread of COVID-19 (coronavirus
disease 2019). If one individual wears a mask, this can affect whether another individual
contracts COVID-19. If individuals are able to be grouped together into clusters, a reasonable
assumption may be that the individuals within a particular cluster can interfere with each other,
but individuals between clusters cannot interfere with one another. This is known as “partial
interference” [Sobel, 2006]. Methods under the partial interference setting have been proposed
for causal estimands of treatment effects; e.g., see Tchetgen Tchetgen and VanderWeele [2012],
Papadogeorgou et al. [2019], Barkley et al. [2020].
Common methods under the observational setting include inverse probability weighting
(IPW) and the parametric g-formula. For example, Tchetgen Tchetgen and VanderWeele [2012],
Papadogeorgou et al. [2019], Barkley et al. [2020] provide consistent estimates in the IPW
setting. However, the estimator can be unstable when propensity scores are near zero, making
it difficult to handle large clusters [Saul and Hudgens, 2017, Chakladar et al., 2019, Liu et al.,
2019]. The parametric g-formula provides an alternative method of estimating causal effects that
combines the g-computation algorithm of Robins [1986] with parametric outcome regression
[Hernán and Robins, 2006]. However, the parametric g-formula requires specifying the outcome
model and is not valid if this model is misspecified.
An alternative to IPW and the g-formula is g-estimation. This method was originally
proposed for structural nested models [Robins, 1989, Robins et al., 1992]. G-estimation can
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perform better than IPW when the positivity assumption may be violated and does not suffer
from the g-null paradox [Vansteelandt and Joffe, 2014]. There are doubly robust g-estimators
that provide consistent estimators as long as at least one model is correctly specified. A drawback
of g-estimation is that it is not commonly used because of the perception that there is a lack
of off-the-shelf software. Dukes and Vansteelandt [2018] have provided a method using a
gamma generalized linear model to obtain g-estimators of causal mean ratios using generalized
estimating equations. However, this does not allow for partial interference. This paper extends
existing g-estimation methods for observational studies to the setting where partial interference
may be present and allows for more flexible forms of the treatment variable.
The motivation behind the methods proposed in this paper was the 2013-14 Democratic
Republic of the Congo (DRC) Demographic and Health Survey (DHS), with the question of
interest focusing on the effect of bed net use on malaria [MPSMRM, MSP, and ICF International,
2014]. This was a nationally representative survey to gather health information, including data
about mosquito net usage and malaria. Data were collected at the household level. Only children
between 6 to 59 months, referred to as “children” for brevity, were tested for malaria, but
covariates and bed net use data were collected for all individuals. In the presented analysis,
a single linkage agglomerative cluster method based on household global positioning system
(GPS) coordinates was used to group individuals into clusters, resulting in a total of 395
clusters with at least one child and measured spatial information and other covariates. After this
algorithm is performed, there are approximately 87,500 individuals with about 7,500 children
with non-missing malaria outcomes (about 96% of children in this age range) in the survey.
Community-level bed net usage has previously been shown to be significantly associated with
malarial protection in children younger than five years old [Levitz et al., 2018]. In the DRC
data, the proportion of malaria in children who do not use bed nets is inversely associated with
the proportion of bed net usage in the cluster for clusters with at least one child who did not
use a bed net (Spearman correlation of rs = −0.16, p = 0.002), suggesting that there may be
interference within clusters. Figure 4.8 displays this inverse relationship. The inferential goal is
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Figure 4.8: Malaria Bed Net Study in the Democratic Republic of the Congo. This figure
displays bed net usage of the entire cluster vs prevalence of malaria in children who do not use
bed nets. Points have been vertically jittered by 0.015. Circle size corresponds to the number
of children who do not use bed nets in the cluster, with larger circle sizes indicating larger
numbers.
The outline of the remainder of this paper is as follows. In Section 4.2, notation, estimands,
estimators, and effects of interest are described. Simulation results for the proposed estimators
in finite samples are presented in Section 4.3. In Section 4.4, the proposed estimators are applied
to the DRC data to investigate the effect of bed net use on malaria. A discussion is presented in
Section 4.5.
4.2 Methods
4.2.1 Notation and Assumptions
Let there be Ni individuals in cluster i for i = 1, . . . ,m. Some individuals within each
cluster may receive treatment, such as a bed net. Denote the binary treatment indicator for
individual j in cluster i by Aij , and let Ai = (Ai1, Ai2, . . . , AiNi) represent the vector of
treatment indicators for all individuals in the cluster. Denote the proportion of treated individuals
in cluster i by Si = (
∑Ni
j=1Aij)/Ni. Represent the outcome at the cluster level by Yi. Depending
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on the outcome of interest, Yi can be defined differently. In the DRC analysis, Yi may be
defined as the proportion of children with malaria in a cluster. Let Li represent a vector of
cluster-level covariates, including Ni. Denote the observed random variables for cluster i by
Oi = {Li, Si, Yi}, and assume there are m observed independent and identically distributed
copies O1, . . . , Om. For ease of notation, the subscript i is omitted when not needed.
Assume that there is no interference between clusters, but there may be interference between
individuals within the same cluster, i.e., partial interference. For example, one individual’s bed
net usage may affect if another individual in the same cluster gets malaria in the DRC analysis.
Let A(Ni) denote the set of all vectors of Ni binary entries for a cluster of size Ni, where a
vector of potential treatment statuses is ai = (ai1, ai2, . . . , aiNi) ∈ A(Ni). Let Y ai represent the
potential outcome if, possibly counter to fact, cluster i had been exposed to ai ∈ A(Ni). When
Ai = ai, Y ai = Yi. Cluster i has 2
Ni potential outcomes.
Assume that only the proportion of treated individuals is important, not the particular
individuals themselves. This assumption is also known as stratified interference [Hudgens and







a = Y a
′ .
Let Y si represent the potential outcome for any a where (
∑Ni
j=1 aij)/Ni = s for cluster i. Assume
exchangeability conditional on L at the cluster level, i.e.,
Y s ⊥ S|L for s ∈ {0, 1/N, 2/N, . . . 1}. (4.13)
This assumption reduces the number of potential outcomes for cluster i to Ni + 1.
4.2.2 Estimands and Effects of Interest
Ratios of expected outcomes when the proportion of treated individuals is changed can
provide information about the population-level effects on interventions, such as bed net use in
the DRC data. Treatment effects in the absence of interference are often defined as contrasts in
expected outcomes when all individuals receive treatment versus where no individuals receive
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treatment. This paper considers a range of contrasts where the proportion of treated individuals,
S, varies.





for s ∈ {0, 1/N, 2/N, . . . , 1} where ψ is a row vector of parameters of interest and f is a
some (column) vector-valued function of s. For example, f(s) = (s, s2, s3)>. The special case
f(s) = s is the model considered by Dukes and Vansteelandt [2018]. In the DRC analysis, the
causal contrast of interest for the case where f(s) = s, exp(ψs), is the ratio of the expected
proportion of individuals with malaria when proportion s of individuals are treated compared to
the scenario when no individuals are treated.
For all effects, the estimand of the effect can be written as (4.14) with different definitions
of Y . The overall effect compares the average disease outcome among all individuals in a
cluster when s individuals are treated versus when no individuals are treated. This effect may
be the most relevant to public health policy because it is likely that there will be a mixture
of individuals who would and who would not choose to receive treatment in a population of
interest. For inference about the overall effect, the proportion of outcomes in all individuals
in a cluster is represented by Yi. In the DRC analysis, Yi is the proportion of all children with
malaria.
Spillover effects can be defined among only untreated individuals in a cluster and among
only treated individuals in a cluster. The effect of treatment, if one exists, that untreated
individuals may experience from being surrounded by other treated individuals is quantified by
the spillover effect when untreated. Let Yi be the proportion of outcomes in untreated individuals
in cluster i for the spillover effect when untreated, and let Yi = 0 if there are no untreated
individuals in the cluster. For the DRC analysis, the proportion of children who do not use bed
nets with malaria will be Yi. The spillover effect when treated can be defined analogously. In the
DRC analysis, the proportion of children who use bed nets with malaria will be Yi. In addition,
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for the spillover effect when treated, s∗ = 1− s is used in place of s. This effect compares the
proportion of individuals with malaria when the proportion of treated individuals is s∗ to that
when all individuals are treated.
4.2.3 Estimators
Suppose we fit by maximum likelihood a correctly specified finite dimensional model for
S|L with parameter vector ρ. Let e(L; ρ) denote E[S|L] with parameters ρ. In this paper, S is
assumed to follow a binomial distribution with parameters N and e(L; ρ) = expit(ρ0 + ρ1L).
Denote the maximum likelihood estimate of ρ as ρ̂. Consider the model
E[Y |L, S] = exp(ω(L) + ψf(S)) (4.15)
where ω(L) is the unknown effect of L in the true outcome model. Extending the method
in Dukes and Vansteelandt [2018] to handle a general function f(S) in the case of partial
interference, a consistent estimator of ψ can be obtained by fitting a gamma generalized linear
model with a log link for the outcome Y
E[Y |S,L] = exp(β0 + β1E{f(S)|L; ρ̂}+ ψf(S)). (4.16)
The estimator ψ̂SR is the solution to
n∑
i=1
d(Li; ρ̂, β̂0, β̂1)[f(Si)− E{f(Si)|Li; ρ̂}][Yi exp(−ψf(Si))− g(L; ρ̂, β̂0, β̂1)] = 0 (4.17)
where d(L; ρ̂, β̂0, β̂1) = exp(−β̂0 − β̂1E{f(Si)|Li; ρ̂}), g(L; ρ̂, β̂0, β̂1) = exp(β̂0 +
β̂1E{f(Si)|Li; ρ̂}), and β̂ = (β̂0, β̂1) are the maximum likelihood estimates for the model
in (4.16). The estimate of ψ from fitting the gamma generalized linear model in (4.16) is
equivalent to finding the value of ψ that solves (4.17). Dukes and Vansteelandt [2018] show
this equivalence in the appendix of their paper for the case when f(S) = S. The more general
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case considered here is shown in Appendix B. If the model for S|L is correctly specified and
model (4.15) holds, then ψ̂SR is a consistent estimator for ψ. Following Dukes and Vansteelandt
[2018], this estimator will be referred to hereafter as the “singly robust” estimator because it
requires both the S|L model and model (4.15) to be correct. If either S|L or (4.15) do not hold,
then (4.17) is not necessarily unbiased and therefore ψ̂SR is not consistent.
A doubly robust estimator can be constructed as well by fitting a gamma generalized linear
model with a log link for the outcome Y and adjusting for all covariates L as follows
E[Y |S,L] = exp(β0 + β1E{f(S)|L; ρ̂}+ βLL + ψf(S)). (4.18)
The estimate of ψ from fitting the gamma generalized linear model in (4.18) is equivalent to
finding the value of ψ̂DR that solves
n∑
i=1
d̃(Li; ρ̂, β̂0, β̂1)[f(Si)− E{f(Si)|Li; ρ̂}][Yi exp(−ψf(Si))− g̃(L; ρ̂, β̂0, β̂1)] = 0 (4.19)
where d̃(L; ρ̂, β̂0, β̂1) = exp(−β̂0 − β̂1E{f(Si)|Li; ρ̂} − β̂LLi), g̃(L; ρ̂, β̂0, β̂1) = exp(β̂0 +
β̂1E{f(Si)|Li; ρ̂} + β̂LLi), and β̂ = (β̂0, β̂1, β̂L) are the maximum likelihood estimates for
the model in (4.18). As long as either the outcome model for the untreated E[Y |L, S = 0] =
exp(β0 + βLL) or the treatment model S|L is correctly specified, but not necessarily both, then
ψ̂DR is consistent for ψ. This estimator is therefore doubly robust. Finally, the estimators for
the effects of interest can be defined as exp(ψ̂f(s)) for s ∈ {0, 1/N, 2/N, . . . , 1} using either
ψ̂SR or ψ̂DR. An exponential model can be fit instead of a gamma generalized linear model for
the outcome as the estimates will be the same in either case. In Appendix B, these estimators
are shown to be consistent and asymptotically Normal using standard large-sample estimating
equation theory as described by [Stefanski and Boos, 2002]. The empirical sandwich estimators,
which are consistent estimators of the asymptotic variances, can be used to construct Wald
confidence intervals (CIs). These standard error estimates account for estimating e(L), so the
variance estimator is not conservative.
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4.3 Simulations
In order to evaluate finite sample properties of the proposed g-estimator, simulation studies
were performed for the special case when f(s) = s. Two separate studies were done for two
of the target estimands: the overall effect and the spillover effect when untreated. Since the
spillover effect when treated is essentially the same process as the spillover effect when untreated,
with the exception of recoding the treatment variable, it was omitted for the simulation studies.
For the overall effect simulation study, 1000 datasets of m = 350 clusters were stochastically
generated as follows:
(i) The number of individuals per cluster Ni was simulated such that P (Ni = 40) =
0.4, P (Ni = 50) = 0.35, and P (Ni = 60) = 0.25.
(ii) Two cluster level covariates L1i and L2i were generated with L1i following a Normal
distribution with mean 40 and standard deviation 10, and L2i such that P (L2i = 0) =
5/18, P (L2i = 1) = 3/18, P (L2i = 2) = 4/18, P (L2i = 3) = 5/18, P (L2i = 4) =
1/18.
(iii) For each cluster, the number of treated individuals was drawn from a Binomial distribution
with parameters Ni and e(Li; ρ) = expit(ρ0 + ρ1L1i + ρ2L2i) where (ρ0, ρ1, ρ2) =
(logit(0.55),−0.01,−0.01). For each cluster, the proportion of individuals treated per
cluster, Si, was calculated by dividing the number of treated individuals by Ni.
(iv) For each cluster, the outcome Yi was set equal to Xi/Ni where Xi was Poisson with pa-
rameter λyi = exp(β0+ψSi+β1L1i+β2L2i) where (β0, ψ, β1, β2) = (log(0.6Ni),−0.6,
− 0.01,−0.01).
This process was repeated for the spillover effect when untreated. For this effect, Yi was set equal
to Xi/{Ni(1−Si)} where Xi was Poisson with parameter λyi with β1 = log(0.6{Ni(1−Si)}).
If there were no untreated individuals, then Yi = 0.
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Binomial regression models for S were fit with main effects for L1, L2 to calculate fitted
values e(L; ρ̂). Gamma regression models with a log-link for Y were fit with main effects
for S, e(L; ρ̂). In the case of the doubly robust estimator, these models had main effects for
S, e(L; ρ̂), L1. As noted in Dukes and Vansteelandt [2018], including both e(L; ρ̂) and all
covariates L can sometimes result in failed convergence or unstable estimates due to collinearity.
This was the case here when including both L1, L2, so just L1 was used instead. Note that these
models were correctly specified. The asymptotic variance of the estimators was calculated using
the empirical sandwich variance estimator, which is described in Appendix B. Wald-type 95%
CIs were calculated with these variance estimates.
In the case where the model for S is misspecified, the true treatment model uses e(L; ρ) =
probit−1(−0.002L21 + 0.5
√
L2). A binomial regression model for S is then fit with main effects
for L1, L2 as before. In the case where the model for Y is misspecified, the true outcome model
uses λy = exp(log(0.3K) + ψS − 0.5I(55 > L1 > 35) + 0.005I(L2 < 3)) where K = N for
the overall effect or {Ni(1− Si)} for the spillover effect when untreated. Gamma regression
models are then fit as mentioned above.
The estimates for each dataset were compared to the true value of ψ with a summary of
these results in Table 4.4. For the singly robust estimator, the average bias is negligible when
the S|L model is correctly specified, and the Wald-type 95% CIs contained the true parameter
values in approximately 95% of the simulated datasets. When the S|L model is not correctly
specified, the estimator is biased and coverage is below 90%, as expected. For the doubly robust
estimator, the average bias of the estimators was negligible when both models are correctly
specified, when the E[Y |L, S = 0] model is correctly specified (but the S|L model is incorrect),
and when the treatment model S|L is correctly specified (but E[Y |L, S = 0] is incorrect). For
these scenarios, the Wald-type 95% CIs contained the true parameter values in approximately
95% of the simulated datasets. When both models are misspecified, the estimators are biased
with poor coverage. The average of the estimated sandwich standard errors was approximately
equal to the empirical standard errors, with standard error ratios of approximately 1. These
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simulations demonstrate that the estimators performed well. Additional simulations for the
overall effect for the case when f(s) = s+ s2 can be seen in Appendix B.
Table 4.4: Summary of simulation study results as described in Section 4.3. Truth: true value of
ψ targeted by the estimator. Bias: average bias of the g-estimates over 1000 datasets. Cov%:
empirical coverage of Wald 95% CIs. ASE: average of estimated sandwich standard errors.
ESE: empirical standard error. SER: ASE/ESE. Group: group of interest where All denotes all
individuals, Untreated denotes untreated individuals.
Scenario Group Bias Relative Bias Cov% ASE ESE SER
Singly robust
S model correct All 0.003 -0.5% 96% 0.20 0.19 1.03
Untreated -0.002 0.3% 94% 0.28 0.29 0.95
S model incorrect All 0.41 -68% 76% 0.34 0.36 0.96
Untreated 0.42 -70% 80% 0.41 0.43 0.95
Doubly Robust
Both correct All 0.003 -0.5% 96% 0.20 0.19 1.05
Untreated -0.003 0.5% 94% 0.28 0.29 0.96
S model incorrect All -0.027 4.5% 94% 0.35 0.36 0.97
Untreated -0.017 2.8% 93% 0.42 0.44 0.96
Y model incorrect All -0.003 0.5% 97% 0.35 0.31 1.15
Untreated -0.030 5% 95% 0.44 0.42 1.07
Both incorrect All 1.5 -250% 17% 0.50 0.53 0.94
Untreated 1.5 -250% 28% 0.58 0.59 0.97
4.4 Analysis of Bed Net Use on Malaria in the Democratic Republic of the Congo
To measure the effects of bed nets on malaria in children when varying the proportion of
children who use bed nets in the DRC, the methods described above can be applied. Individuals
within 10 kilometers are grouped into larger clusters using a single linkage agglomerative cluster
method, as mentioned in Section 4.1. The maximum distance between any two households in
the same cluster was constrained to not exceed 10 kilometers The maximum flight distance of
an Anopheles mosquito is 10 kilometers, which was the basis for this choice of distance [Janko
et al., 2018]. In order to prevent identification of participants, the GPS coordinates in the data
that were used in this algorithm are randomly displaced from the real location. Rural clusters
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were displaced up to 5 kilometers, while urban clusters were displaced up to 2 kilometers
[MPSMRM, MSP, and ICF International, 2014]. There were 395 clusters with at least one child
and were not missing spatial information and other covariates after this clustering algorithm.
Partial interference is assumed at the cluster level. Figure 4.9 displays the number of children
per cluster, as well as the proportion of these children who use bed nets.
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Figure 4.9: Malaria Bed Net Study in the Democratic Republic of the Congo. Left panel:
number of children with a measured malaria outcome per cluster. Right panel: proportion of
children who use bed nets per cluster.
For each cluster, Y , S, andN were defined based only on children with a measured outcome
because malaria was only measured in children. Exchangeability was assumed conditional on
the cluster-level proportion of women, as well as cluster-level averages of building material,
urbanicity, altitude, age, temperature in the month of the survey, total precipitation in a 10
kilometer radius the month before the survey, and proportion of agricultural land cover within
a 10 kilometer radius in 2013. The building material variable was defined as the sum of roof
and wall materials for each individual within a cluster, similar to Levitz et al. [2018]. Natural
materials were worth 0 points, rudimentary materials 1 point, and finished materials 2 points, so
the building material variable is an integer between 0 and 4 points.
Causal mean ratios conditional on L can be constructed using ψ̂SR and ψ̂DR for the overall
effect, spillover effect when treated, and spillover effect when untreated. While the methods
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presented in Section 4.2 involve a comparison to the case when no children are treated (or
when all children are treated in the case of the spillover effect when treated), this may not be
of interest to policy makers. Instead, the analysis presented here compares the estimated mean
proportion of children in each group of interest with malaria when a given proportion of children
are treated versus the case in the actual data where 55% of children are treated on average. First,
the choice of f(S) was investigated to see if this affects the results in the malaria dataset. The
estimated causal mean ratios exp(ψ̂(f(S)− f(0.55))) for different functions f(S) can be seen
in Figure 4.10 for f(S) = S, S + S2, S + S2 + S3, and I(0.2 < S ≤ 0.4) + I(0.4 < S ≤
0.6) + I(0.6 < S ≤ 0.8) + I(0.8 < S ≤ 1). For example, the estimated causal mean ratio
for f(S) = S + S2 is exp(ψ̂0(S − 0.55) + ψ̂1(S2 − 0.552)). The functional form of S can
change the behavior of the estimated causal mean ratio. For the flexible models, the estimated
causal mean ratio increases and then decreases, while for the simple case f(S) = S, this ratio
decreases. In comparison with the piecewise constant model, the quadratic and cubic models
appear to fit better than linear model.
Figure 4.11 displays the estimated causal mean ratios when f(S) = S + S2. For the overall
effect, this ratio compares the estimated mean proportion of all children with malaria when
a given proportion of children are treated versus when 55% of children are treated. For the
spillover effect when treated, this ratio compares the estimated mean proportion of treated
children with malaria when a given proportion of children are treated versus when 55% of
children are treated. The spillover effect when untreated is defined similarly with untreated
children as the population and the comparison of interest is to the case when 55% of children
are treated. The estimated ratios increase and then decrease as the proportion treated increases.
For comparisons where the proportion of children treated is greater than 55%, all confidence
intervals in Figure 4.11 exclude 1, indicating that if more than 55% of children in this population
used bed nets, there is a significant protective effect of bed net use in all children, in treated
children, and in untreated children.
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Figure 4.10: Estimated Causal Mean Ratios Using Different Functions of Treatment from the
Malaria Bed Net Study. The plotted lines are the estimated causal mean ratios exp(ψ̂(f(S)−
f(0.55))) for different functions f(S). Solid black lines represent f(S) = S, dashed lines
represent f(S) = S +S2, long dashed lines represent f(S) = S +S2 +S3, and solid dark gray
lines represent f(S) = I(0.2 < S ≤ 0.4) + I(0.4 < S ≤ 0.6) + I(0.6 < S ≤ 0.8) + I(0.8 <
S ≤ 1). The overall effect, spillover effect when untreated, and spillover effect when treated
compare the expected proportion of malaria cases in all children, untreated children, and treated
children, respectively, when the proportion treated is a given value compared to the expected
proportion of malaria cases when 55% of children are treated.
Sensitivity analyses were performed to investigate if the choice of 10 kilometers for the
single linkage agglomerative clustering algorithm affects the results in the malaria dataset.
The clustering algorithm was performed using 5 kilometers and 2.5 kilometers as well. There
were 415 clusters for the 5 km analysis and 445 clusters for the 2.5 km analysis that were not
missing spatial information and have at least one child. The estimated causal mean ratios where
f(S) = S + S2 can be seen in Figure 4.12 and are very similar to those when using 10 km,
with a maximum absolute difference of 0.12 for the singly robust results and 0.11 for the doubly
robust results. The conclusions are the same for all choices of distance.
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Figure 4.11: Estimated Causal Mean Ratios from the Malaria Bed Net Study. Shaded regions
indicate 95% CIs. Dashed black lines represent the singly robust estimator, and solid gray lines
represent the doubly robust estimator. The overall effect, spillover effect when treated, and
spillover effect when untreated compare the expected proportion of malaria cases in all children,
treated children, and untreated children, respectively, when the proportion treated is a given
value compared to the expected proportion of malaria cases when 55% of children are treated.
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Figure 4.12: Sensitivity Analysis for Estimated Causal Mean Ratios from the Malaria Bed Net
Study. Solid lines represent 10 km, dotted lines represent 5 km, and dashed lines represent
2.5 km. The overall effect, spillover effect when treated, and spillover effect when untreated
compare the expected proportion of malaria cases in all children, treated children, and untreated
children, respectively, when the proportion treated is a given value compared to the expected
proportion of malaria cases when 55% of children are treated.
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4.5 Discussion
G-estimation is an alternative to IPW and the parametric g-formula. Unlike IPW, the
proposed estimator can handle large cluster sizes [Saul and Hudgens, 2017, Chakladar et al.,
2019, Liu et al., 2019]. The proposed estimator is also not subject to the g-null paradox, unlike
the parametric g-formula. Both IPW and the parametric g-formula rely upon parametric models.
G-estimation is a semi-parametric approach and is more flexible than IPW or the parametric
g-formula. Both singly and doubly robust estimators are provided here with a general function
of the treatment variable that allows for more flexible models. In order for the estimators to be
consistent, the appropriate parametric models must be correctly specified; future research could
explore relaxing the parametric assumptions further.
The causal effects of treatment mentioned in this paper may be of interest to policy makers.
Populations of interest may have a mixture of those who would and would not choose to
be treated, so public health officials could investigate treatment effects in different parts of
these populations. Recently, IPW and g-formula methods for the partial interference setting
in observational studies have been proposed [Barkley et al., 2020, Kilpatrick and Hudgens,
2021]. Both methods consider counterfactual scenarios that change the distribution of treatment
according to different policies. However, this paper does not consider this type of stochastic
intervention, so some effect estimates may not make sense depending on cluster size, i.e., the
effect estimates for a proportion treated of 50% may not make sense for an odd sized cluster.
However, the causal mean ratio curves presented above can still help guide policy makers. The
methods presented in this paper are focused on the infectious disease setting, but the methods
can also be applied to other settings with partial interference.
Code and Data Availability
R code to replicate the more complex simulation study in Appendix B is available at
https://github.com/KilpatrickKW. The DRC survey data is available upon request
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Causal inference can be a powerful tool to evaluate treatment effects. In a real world setting,
it is likely that some individuals can interfere with each other, i.e., one individual’s treatment can
affect another individual’s outcome. The proposed methods in this dissertation assume partial
interference where individuals can be placed into groups, and individuals within the same group
can interfere with each other but not with individuals in other groups. By accounting for the
possible presence of interference, different treatment effects can be calculated. Since the real
world population will likely be made up of individuals who will and will not choose to receive
treatment, calculating different treatment effects in these different populations can be useful
for public health policies. In this dissertation, methods are proposed to go beyond the usual
causal effect that compares the average outcome when all individuals are treated versus when
no individuals are treated.
The first setting considered in this dissertation was cluster-randomized trials. Estimands
for the overall, indirect, and total effects of vaccination are defined. This chapter can be useful
for investigators when designing and analyzing a cluster-randomized trials, especially since
there is currently a movement in clinical trials literature to carefully define estimands of interest.
A Vi polysaccharide (typhoid) vaccine trial was the motivating example for this chapter [Sur
et al., 2009b]. Individuals within clusters chose whether or not to participate in this trial. The
number of cases of typhoid per 1000 persons over a two year period was found to decrease
when receiving the Vi vaccine for all individuals, for non-participants, and for participants.
Future research related to this chapter could be to develop methods accounting for possible
confounding in order to define the estimator of the direct effect.
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We then move to the setting of observational studies for the following two chapters. In
Chapter 3, we extend the G-formula to the case of partial interference when the scientific
question of interest is the efficacy of different treatment policies. The estimands of interest
were shown to be identifiable from observational data, and the proposed estimators were shown
to be consistent and asymptotically normal using estimation equation theory. The proposed
estimators were applied to the 2013-14 DRC Demographic and Health Survey to investigate the
causal effect of bed net use on malaria. As the proportion of children who use bed nets increases,
the expected number of cases of malaria decreased for all children and treated children. For
non users, increasing bed net use seems to either have no benefit or a modest benefit. For this
chapter, future research could include using semiparametric or nonparametric models in order
to relax the parametric assumptions made here.
Finally, in Chapter 4, g-estimation is extended to the case of partial interference where
the question of interest is again the effect of different treatment policies. We showed that the
estimands of interest are identifiable from observed data, and that the proposed estimators are
consistent and asymptotically normal. The proposed estimators were applied to 2013-14 DRC
Demographic and Health Survey to again investigate the causal effect of bed net use on malaria.
Using this method, the estimated causal mean ratios were found to decrease as the proportion of
bed net users increased, indicating that there are fewer cases of malaria as more individuals use
bed nets. Future research building from this chapter could be to explore relaxing the parametric
assumptions further.
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APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 3
The g-formula estimators in Section 3.2.3 can be shown to be consistent and asymptotically
Normal using standard large-sample estimating equation theory. Let θ = (ρ, γ0α, γ0α′ , β, µα,
µα′ , δ(α, α
′)). Estimating functions for ρ̂ and β̂ are given by score equations corresponding to
the binomial models P (S = s|L; ρ) and P (Y = y|S = s,L; β). Denote these score equations
by ψρ(O; θ) and ψβ(O; θ). For policy α, let ψγ0α(O; θ) = Eα(S|L = l; γ0α, ρ1) − α where




E(Y |S = s,L; β)Pα(S = s|L; γ0α, ρ)− µα.
Define ψδ(α,α′)(O; θ) = ψµα(O; θ) − ψµα′ (O; θ), and let ψθ = (ψρ, ψγ0α , ψγ0α′ , ψβ, ψµα , ψµα′ ,
ψδ(α,α′))
>. Then the estimator θ̂ = (ρ̂, γ̂0α, γ̂0α′ , β̂, µ̂α, µ̂α′ , δ̂(α, α′)) is the solution to the vector
estimating equation
∑m
i=1 ψθ(O; θ) = 0.
It is straightforward to show these estimating equations are unbiased. Because ψρ(O; θ)
and ψβ(O; θ) are score equations,
∫
ψρ(O; θ)dFO(O) = 0 and
∫
ψβ(O; θ)dFO(O) = 0 where
FO(O) denotes the distribution of the observed variables O. For policy α, γ0α is the solution to
(3.10), implying E{ψγ0α(O; θ)} = 0. Next note
E{ψµα(O; θ)} = E{
∑
s∈S

















s|L = l)Pα(S = s|L = l)dFL(l)− µα
= 0
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where the first equality holds assuming the Y |S,L and S|L models are correctly specified and
that Eα(Y |S = s,L = l) = E(Y |S = s,L = l), the second equality by causal consistency, the
third equaltiy from conditional exchangeability, and the last equality from the definition of µα.
From standard large-sample estimating equation theory, it follows that under suitable
regularity conditions, θ̂ →p θ and
√
m(θ̂ − θ) →d N(0,Σ) where Σ = U−1W (U−>) for
U = E{−ψ̇θ(O; θ)}, where ψ̇θ(O; θ) = ∂ψθ(O; θ)/∂θ>, and W = E{ψθ(O; θ)⊗2} [Stefanski
and Boos, 2002]. The asymptotic variance Σ can be consistently estimated by the empirical
sandwich variance estimator Σ̂ = Û−1Ŵ (Û−>) where Û = m−1
∑m






APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 4
The estimators in Section 4.2.3 can be shown to be consistent and asymptotically Normal
using standard large-sample estimating equation theory [Stefanski and Boos, 2002]. Under the
assumptions in Section 4.2, the model in equation (4.14) is equivalent to assuming E(Y |S,L) =
exp(w(L) + ψf(S)) for some unspecified function w(L). The goal is to draw inference about
ψ based on m iid copies of O = (L, S, Y ). Suppose we fit by maximum likelihood a correct
specified finite dimensional model for S|L with parameter vector ρ. Next fit Gamma glm
E(Y |S,L) = µ where µ = exp(β0 + β1E{f(S)|L; ρ̂} + ψf(S)) and where ρ̂ is MLE of ρ.
Let ρ = (ρ0, ρ1) and β = (β0, β1, βL) where βL is only included if using the doubly robust
estimator. Let θ = (ρ, β, ψ). Estimating functions for θ̂ are given by score equations; denote
these score equations by γρ(O; ρ), γβ(O; θ), γψ(O; θ). Let γθ = (γρ, γβ, γψ)>. The estimator
θ̂ = (ρ̂, β̂, ψ̂) is the solution to the vector estimating equation
∑m






γβ0(Oi; ρ, β0, β, ψ)
γβ1(Oi; ρ, β0, β, ψ)





















γβ0(Oi; ρ, β0, β, ψ)
γβ1(Oi; ρ, β0, β, ψ)










E{f(S)|Li; ρ}(Yiµ−1i − 1)
(f(Si)− E{f(S)|Li; ρ})(Yiµ−1i − 1)

It is straightforward to show that the estimating equations are unbiased. Define β∗0 and β
∗
1 to be








1 , ψ) = 0. Be-
cause γρ(O; ρ) and γβ(0; θ) are score equations,
∫













1){f(S)− E{f(S)|L; ρ}}(Y exp(−ψf(S))− g(L; ρ, β∗0 , β∗1))
where d(L; ρ, β0, β1) = exp(−β0 − β1E{f(S)|L; ρ}) and g(L; ρ, β0, β1) = exp(β0 +
β1E{f(S)|L; ρ}). From Robins [1994] it follows that E(γ∗ψ(O; ρ, β∗0 , β∗1 , ψ)) = 0 if the treat-
ment model and structural models above are correctly specified. Using obvious shorthand
E(γ∗ψ) = ES,L[d(f(S)− E{f(S)|L; ρ}){E(Y exp(−ψf(S))|S,L)− g}]
= ES,L[d(f(S)− E{f(S)|L; ρ}){exp(w(L))− g}] = 0
where first equality holds by the assumed structural model and the second equality holds
assuming the treatment model is correct.
Consider the estimator from above, but suppose now that instead we fit Gamma glm
E(Y |S,L) = µ where µ = exp(β0 + β1E{f(S)|L; ρ̂} + βLL + ψf(S)). The estima-
tor θ̂ = (ρ̂, β̂, ψ̂) is the solution to estimating equations listed above with the addition of
γβL(Oi; ρ, β0, β1, ψ) = Li(Yiµ
−1
i − 1). Define β∗0 , β∗1 , and β∗L to be values of β0, β1 and βL such




2 , ψ)) = 0 for γβ0 , γβ1 , γβL . By the previous arguments, ψ̂ is CAN for
ψ if the treatment model is correctly specified. Alternatively, suppose we can assume that
E(Y |L, S = 0) = exp(β0 + βLL)
such that β∗0 = β0, β
∗
1 = 0, β
∗
L = βL. Then it follows that E(Yiµ
−1
i |Si,Li) = 1, implying
E(γβ) = 0 and E(γ∗ψ) = 0 even if the treatment model is misspecified. Thus ψ̂ is CAN for ψ if
the treatment model is correct or the Y |S = 0,L model is correct, i.e., the estimator is doubly
robust.
It follows from standard large-sample estimating equation theory that under suitable
regularity conditions, θ̂ →p θ and
√
m(θ̂ − θ) →d N(0,Σ) where Σ = U−1W (U−>) for
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U = E{−γ̇θ(O; θ)}, where γ̇θ(O; θ) = ∂γθ(O; θ)/∂θ>, and W = E{γθ(O; θ)⊗2} [Stefanski
and Boos, 2002]. The asymptotic variance Σ can be consistently estimated by the empiri-








Additional simulations were performed for the overall effect when f(s) = s + s2. Steps
(i)-(iv) in Section 4.3 were performed using true values of ψ0 = −3, ψ1 = 1.5 for λy =
exp(β0 + β1L1i + β2L2i + ψ0Si + ψ1S
2
i ). When the model for S model is misspecified, the
true treatment model uses e(L; ρ) = probit−1(−0.4I(55 > L1 > 35) + 0.2I(L2 < 3)). When
the model for Y is misspecified, the true outcome model uses λy = exp(log(0.7N) + ψ0S +
ψ1S
2 − 0.5I(55 > L1 > 35) + 0.3I(L2 < 3)). Binomial regression models for S were fit with
main effects for L1, L2. Gamma regression models with a log link for Y were fit with main
effects for S, S2, E[S|L; ρ̂], E[S2|L; ρ̂]. In the case of the doubly robust estimator, these models
also had main effects for both L1, L2. These estimators performed as expected. The singly
robust estimator may be robust to some misspecifications, but this could be due to the choice of
parameters and is not guaranteed.
Scenario ψ Group Bias Relative Bias Cov% ASE ESE SER
Singly robust
S model correct ψ0 All -0.014 0.5% 94% 2.29 2.33 0.98
ψ1 All 0.012 0.8% 94% 2.57 2.65 0.97
S model incorrect ψ0 All -0.26 8.7% 94% 1.31 1.32 0.99
ψ1 All 0.28 18% 94% 1.43 1.45 0.99
Doubly Robust
Both correct ψ0 All -0.019 0.6% 94% 2.29 2.34 0.98
ψ1 All 0.016 1.1% 94% 2.57 2.66 0.96
S model incorrect ψ0 All 0.042 -1.4% 94% 1.32 1.34 0.99
ψ1 All -0.057 -3.8% 94% 1.44 1.46 0.98
Y model incorrect ψ0 All 0.069 -2.3% 93% 2.14 2.28 0.94
ψ1 All -0.085 -5.7% 93% 2.40 2.57 0.93
Both incorrect ψ0 All 0.97 -32% 85% 1.16 1.26 0.92
ψ1 All 0.61 40% 89% 1.24 1.34 0.93
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Sample R Code
The full code used for the simulations in the previous section is available at https://github.
com/KilpatrickKW. The following code demonstrates how to fit both models and find
standard error estimates using the geex package in R.
#--------------------------------------------------------------------------






# now find E[Sˆ2|L]
ehat_s<-list()
sum_over_s<-list()
for (i in simdataset$cluster){
Nval<-simdataset$N[i] #max num in cluster











































for (i in length(Y)){
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Nval<-data$N[i] #max num in cluster
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